Additional Information
Book Details
Abstract
Learn to think like a nurse with the bestselling nursing care planning book on the market! Covering the most common medical-surgical nursing diagnoses and clinical problems seen in adults, Nursing Care Plans: Diagnoses, Interventions, and Outcomes, 9th Edition contains 217 care plans, each reflecting the latest best practice guidelines. This new edition specifically features three new care plans, two expanded care plans, updated content and language reflecting the most current clinical practice and professional standards, enhanced QSEN integration, a new emphasis on interprofessional collaborative practice, an improved page design, and more. It’s everything you need to create and customize effective nursing care plans!
- 217 total care plans provide more care plans than any other book.
- Prioritized care planning guidance internally organizes care plans from "actual" to "risk" diagnoses, from general to specific interventions, and from independent to collaborative/interprofessional interventions, to help you select the most important, priority interventions for your particular patients.
- Introductory chapter explains the components of nursing care plans, NANDA-I nursing diagnoses, the NIC and NOC systems, and how to create nursing care plans.
- Latest NANDA-I taxonomy is integrated throughout to incorporate the very latest NANDA-I nursing diagnoses, related factors, and defining characteristics.
- Latest NIC and NOC labels ensure you are made aware of appropriate interventions and outcomes.
- 70 nursing diagnosis care plans include the most common/important NANDA-I nursing diagnoses, providing the building blocks for you to create your own individualized care plans.
- 150 disorders care plans cover virtually every common medical-surgical condition, organized by body system.
- Health promotion and risk factor management care plans emphasize the importance of preventive care and teaching for self-management.
- Basic nursing concepts care plans focuses on concepts that apply to disorders found in multiple body systems.
- Nursing diagnosis care plan format includes a definition/explanation of the diagnosis, related factors, defining characteristics, expected outcomes, related NOC Outcomes and NIC Interventions, ongoing assessment, and therapeutic interventions.
- Disorders care plan format covers synonyms for the disorder (for ease in cross referencing), a definition, common related factors, defining characteristics, expected outcomes, NOC Outcomes and NIC Interventions, ongoing assessment, and therapeutic interventions for each relevant nursing diagnosis.
- Independent and collaborative/interprofessional interventions are highlighted by special icons that differentiate between independent and collaborative/interprofessional interventions.
- 30 online care plans are hosted on the Evolve companion site in a user-friendly PDF format that allows you to cut-and-paste care plan contents to create customized care plans.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | cover | ||
Evolve page | IFC1 | ||
Nursing Care Plans | i | ||
Copyright Page | ii | ||
Contributors | iii | ||
Reviewers | iii | ||
Preface | v | ||
Table Of Contents | vii | ||
1 Using Nursing Care Plans to Individualize and Improve Care | 1 | ||
Introduction | 1 | ||
Components of These Nursing Care Plans | 1 | ||
Nursing Diagnoses Taxonomy, and Interventions and Outcomes Classifications | 2 | ||
Using Nursing Care Plans: Diagnoses, Interventions, and Outcomes | 3 | ||
Developing an Individualized Care Plan | 3 | ||
The Assessment | 3 | ||
Performing the Assessment | 3 | ||
Using General Versus Specific Care Plan Guides | 5 | ||
General | 5 | ||
Specific | 5 | ||
A Focus on Optimizing Health | 5 | ||
Other Common Themes | 5 | ||
Ensuring Quality and Safety | 5 | ||
Tools for Performance Improvement | 6 | ||
Development of Patient Education Materials | 7 | ||
A Basis for Clinical Paths | 7 | ||
References | 7 | ||
2 Nursing Diagnosis Care Plans | 8 | ||
Activity Intolerance | 8 | ||
Common Related Factors | 8 | ||
Defining Characteristics | 8 | ||
Common Expected Outcomes | 8 | ||
Ongoing Assessment | 8 | ||
Therapeutic Interventions | 10 | ||
Education/Continuity of Care | 10 | ||
Ineffective Airway Clearance | 11 | ||
Common Related Factors | 12 | ||
Defining Characteristics | 12 | ||
Common Expected Outcome | 12 | ||
Ongoing Assessment | 12 | ||
Therapeutic Interventions | 13 | ||
Education/Continuity of Care | 14 | ||
Latex Allergy Response | 15.e1 | ||
Common Related Factor | 15.e1 | ||
Defining Characteristics | 15.e1 | ||
Common Expected Outcomes | 15.e2 | ||
Ongoing Assessment | 15.e2 | ||
Therapeutic Interventions | 15.e2 | ||
Education/Continuity of Care | 15.e3 | ||
Anxiety | 15 | ||
Common Related Factors | 16 | ||
Defining Characteristics | 16 | ||
Common Expected Outcomes | 16 | ||
Ongoing Assessment | 17 | ||
Therapeutic Interventions | 17 | ||
Education/Continuity of Care | 19 | ||
Risk for Aspiration | 19 | ||
Common Risk Factors | 20 | ||
Common Expected Outcome | 20 | ||
Ongoing Assessment | 20 | ||
Therapeutic Interventions | 21 | ||
Education/Continuity of Care | 22 | ||
Risk for Bleeding | 23 | ||
Common Risk Factors | 23 | ||
Common Expected Outcomes | 24 | ||
Ongoing Assessment | 24 | ||
Therapeutic Interventions | 25 | ||
Education/Continuity of Care | 25 | ||
Risk for Unstable Blood Glucose Level | 26 | ||
Common Risk Factors | 26 | ||
Common Expected Outcome | 26 | ||
Ongoing Assessment | 27 | ||
Therapeutic Interventions | 28 | ||
Education/Continuity of Care | 28 | ||
Disturbed Body Image | 29 | ||
Common Related Factors | 29 | ||
Defining Characteristics | 29 | ||
Common Expected Outcome | 30 | ||
Ongoing Assessment | 30 | ||
Therapeutic Interventions | 30 | ||
Education/Continuity of Care | 31 | ||
Bowel Incontinence | 31 | ||
Common Related Factors | 32 | ||
Defining Characteristics | 32 | ||
Common Expected Outcome | 32 | ||
Ongoing Assessment | 32 | ||
Therapeutic Interventions | 33 | ||
Education/Continuity of Care | 34 | ||
Ineffective Breathing Pattern | 34 | ||
Common Related Factors | 35 | ||
Defining Characteristics | 35 | ||
Common Expected Outcome | 35 | ||
Ongoing Assessment | 35 | ||
Therapeutic Interventions | 36 | ||
Education/Continuity of Care | 37 | ||
Decreased Cardiac Output | 37 | ||
Common Related Factors | 38 | ||
Defining Characteristics | 38 | ||
Common Expected Outcome | 38 | ||
Ongoing Assessment | 38 | ||
Therapeutic Interventions | 40 | ||
Education/Continuity of Care | 40 | ||
Caregiver Role Strain | 41 | ||
Common Related Factors | 42 | ||
Defining Characteristics | 42 | ||
Common Expected Outcomes | 42 | ||
Ongoing Assessment | 42 | ||
Therapeutic Interventions | 43 | ||
Education/Continuity of Care | 44 | ||
Impaired Verbal Communication | 44 | ||
Common Related Factors | 45 | ||
Defining Characteristics | 45 | ||
Common Expected Outcome | 45 | ||
Ongoing Assessment | 45 | ||
Therapeutic Interventions | 47 | ||
Education/Continuity of Care | 48 | ||
Chronic Confusion | 49 | ||
Common Related Factors | 49 | ||
Defining Characteristics | 49 | ||
Common Expected Outcomes | 49 | ||
Ongoing Assessment | 49 | ||
Therapeutic Interventions | 50 | ||
Education/Continuity of Care | 51 | ||
Constipation | 52 | ||
Common Related Factors | 52 | ||
Defining Characteristics | 52 | ||
Common Expected Outcomes | 53 | ||
Ongoing Assessment | 53 | ||
Therapeutic Interventions | 53 | ||
Education/Continuity of Care | 54 | ||
Ineffective Coping | 55 | ||
Common Related Factors | 55 | ||
Defining Characteristics | 55 | ||
Common Expected Outcomes | 56 | ||
Ongoing Assessment | 56 | ||
Therapeutic Interventions | 56 | ||
Education/Continuity of Care | 57 | ||
Readiness for Enhanced Decision-Making | 58 | ||
Defining Characteristics | 58 | ||
Expected Outcomes | 58 | ||
Ongoing Assessment | 59 | ||
Therapeutic Interventions | 59 | ||
Impaired Dentition | 60.e1 | ||
Common Related Factors | 60.e1 | ||
Defining Characteristics | 60.e1 | ||
Common Expected Outcomes | 60.e1 | ||
Ongoing Assessment | 60.e2 | ||
Therapeutic Interventions | 60.e2 | ||
Education/Continuity of Care | 60.e3 | ||
Diarrhea | 61 | ||
Common Related Factors | 61 | ||
Defining Characteristics | 61 | ||
Common Expected Outcomes | 61 | ||
Ongoing Assessment | 61 | ||
Therapeutic Interventions | 63 | ||
Education/Continuity of Care | 64 | ||
Risk for Electrolyte Imbalance | 65 | ||
Common Risk Factors | 65 | ||
Common Expected Outcomes | 65 | ||
Ongoing Assessment | 65 | ||
Therapeutic Interventions | 66 | ||
Education/Continuity of Care | 67 | ||
Disturbed Energy Field | 67.e1 | ||
Common Related Factors | 67.e1 | ||
Defining Characteristics | 67.e1 | ||
Common Expected Outcome | 67.e2 | ||
Ongoing Assessment | 67.e2 | ||
Therapeutic Interventions | 67.e2 | ||
Education/Continuity of Care | 67.e3 | ||
Risk for Falls | 67 | ||
Common Risk Factors | 68 | ||
Common Expected Outcomes | 68 | ||
Ongoing Assessment | 69 | ||
Therapeutic Interventions | 69 | ||
Education/Continuity of Care | 71 | ||
Interrupted Family Processes | 72 | ||
Common Related Factors | 72 | ||
Defining Characteristics | 72 | ||
Common Expected Outcomes | 72 | ||
Ongoing Assessment | 73 | ||
Therapeutic Interventions | 73 | ||
Education/Continuity of Care | 74 | ||
Fatigue | 74 | ||
Common Related Factors | 74 | ||
Defining Characteristics | 74 | ||
Common Expected Outcomes | 75 | ||
Ongoing Assessment | 75 | ||
Therapeutic Interventions | 76 | ||
Education/Continuity of Care | 77 | ||
Fear | 77 | ||
Common Related Factors | 78 | ||
Defining Characteristics | 78 | ||
Common Expected Outcomes | 78 | ||
Ongoing Assessment | 78 | ||
Therapeutic Interventions | 78 | ||
Education/Continuity of Care | 79 | ||
Deficient Fluid Volume | 80 | ||
Common Related Factors | 80 | ||
Defining Characteristics | 80 | ||
Common Expected Outcome | 80 | ||
Ongoing Assessment | 81 | ||
Therapeutic Interventions | 82 | ||
Education/Continuity of Care | 83 | ||
Excess Fluid Volume | 83 | ||
Common Related Factors | 84 | ||
Defining Characteristics | 84 | ||
Common Expected Outcome | 84 | ||
Ongoing Assessment | 84 | ||
Therapeutic Interventions | 86 | ||
Education/Continuity of Care | 86 | ||
Frail Elderly Syndrome | 87 | ||
Common Related Factors | 87 | ||
Defining Characteristics | 87 | ||
Common Expected Outcomes | 87 | ||
Ongoing Assessment | 88 | ||
Therapeutic Interventions | 89 | ||
Education/Continuity of Care | 90 | ||
Impaired Gas Exchange | 92 | ||
Common Related Factors | 92 | ||
Defining Characteristics | 92 | ||
Common Expected Outcome | 92 | ||
Ongoing Assessment | 92 | ||
Therapeutic Interventions | 94 | ||
Education/Continuity of Care | 95 | ||
Grieving | 95 | ||
Common Related Factors | 96 | ||
Defining Characteristics | 96 | ||
Common Expected Outcome | 96 | ||
Ongoing Assessment | 96 | ||
Therapeutic Interventions | 97 | ||
Education/Continuity of Care | 98 | ||
Complicated Grieving | 98.e1 | ||
Common Related Factors | 98.e1 | ||
Defining Characteristics | 98.e1 | ||
Common Expected Outcomes | 98.e1 | ||
Ongoing Assessment | 98.e2 | ||
Therapeutic Interventions | 98.e2 | ||
Education/Continuity of Care | 98.e3 | ||
Ineffective Health Maintenance | 99 | ||
Common Related Factors | 99 | ||
Defining Characteristics | 99 | ||
Common Expected Outcomes | 99 | ||
Ongoing Assessment | 99 | ||
Therapeutic Interventions | 100 | ||
Education/Continuity of Care | 101 | ||
Impaired Home Maintenance | 101.e1 | ||
Common Related Factors | 101.e1 | ||
Defining Characteristics | 101.e1 | ||
Common Expected Outcomes | 101.e1 | ||
Ongoing Assessment | 101.e2 | ||
Therapeutic Interventions | 101.e2 | ||
Education/Continuity of Care | 101.e3 | ||
Ineffective Health Management | 102 | ||
Common Related Factors | 102 | ||
Defining Characteristics | 102 | ||
Common Expected Outcomes | 102 | ||
Ongoing Assessment | 102 | ||
Therapeutic Interventions | 103 | ||
Education/Continuity of Care | 104 | ||
Hopelessness | 105 | ||
Common Related Factors | 105 | ||
Defining Characteristics | 105 | ||
Common Expected Outcomes | 105 | ||
Ongoing Assessment | 105 | ||
Therapeutic Interventions | 106 | ||
Education/Continuity of Care | 107 | ||
Hyperthermia | 107.e1 | ||
Common Related Factors | 107.e1 | ||
Defining Characteristics | 107.e1 | ||
Common Expected Outcomes | 107.e1 | ||
Ongoing Assessment | 107.e1 | ||
Therapeutic Interventions | 107.e2 | ||
Education/Continuity of Care | 107.e2 | ||
Hypothermia | 107.e3 | ||
Common Related Factors | 107.e3 | ||
Defining Characteristics | 107.e3 | ||
Common Expected Outcomes | 107.e3 | ||
Ongoing Assessment | 107.e3 | ||
Therapeutic Interventions | 107.e4 | ||
Education/Continuity of Care | 107.e5 | ||
Functional Urinary Incontinence | 108 | ||
Common Related Factors | 108 | ||
Defining Characteristics | 108 | ||
Common Expected Outcomes | 108 | ||
Ongoing Assessment | 108 | ||
Therapeutic Interventions | 109 | ||
Education/Continuity of Care | 109 | ||
Reflex Urinary Incontinence | 109 | ||
Common Related Factors | 109 | ||
Defining Characteristics | 109 | ||
Common Expected Outcomes | 110 | ||
Ongoing Assessment | 110 | ||
Therapeutic Interventions | 110 | ||
Education/Continuity of Care | 110 | ||
Stress Urinary Incontinence | 111 | ||
Common Related Factors | 111 | ||
Defining Characteristics | 111 | ||
Common Expected Outcomes | 111 | ||
Ongoing Assessment | 111 | ||
Therapeutic Interventions | 112 | ||
Education/Continuity of Care | 112 | ||
Urge Urinary Incontinence | 113 | ||
Common Related Factors | 113 | ||
Defining Characteristics | 113 | ||
Common Expected Outcomes | 113 | ||
Ongoing Assessment | 113 | ||
Therapeutic Interventions | 114 | ||
Education/Continuity of Care | 114 | ||
Risk for Infection | 114 | ||
Common Risk Factors | 115 | ||
Common Expected Outcomes | 115 | ||
Ongoing Assessment | 115 | ||
Therapeutic Interventions | 116 | ||
Education/Continuity of Care | 117 | ||
Insomnia | 118 | ||
Common Related Factors | 118 | ||
Defining Characteristics | 118 | ||
Common Expected Outcome | 118 | ||
Ongoing Assessment | 118 | ||
Therapeutic Interventions | 119 | ||
Education/Continuity of Care | 120 | ||
Decreased Intracranial Adaptive Capacity | 120 | ||
Common Related Factors | 121 | ||
Defining Characteristics | 121 | ||
Common Expected Outcome | 121 | ||
Ongoing Assessment | 121 | ||
Therapeutic Interventions | 122 | ||
Education/Continuity of Care | 123 | ||
Deficient Knowledge | 123 | ||
Common Related Factors | 124 | ||
Defining Characteristics | 124 | ||
Common Expected Outcomes | 124 | ||
Ongoing Assessment | 124 | ||
Therapeutic Interventions | 125 | ||
Education/Continuity of Care | 127 | ||
Sedentary Lifestyle | 128 | ||
Common Related Factors | 128 | ||
Defining Characteristics | 128 | ||
Common Expected Outcomes | 128 | ||
Ongoing Assessment | 128 | ||
Therapeutic Interventions | 129 | ||
Education/Continuity of Care | 130 | ||
Impaired Memory | 131 | ||
Common Related Factors | 131 | ||
Defining Characteristics | 131 | ||
Common Expected Outcomes | 131 | ||
Ongoing Assessment | 132 | ||
Therapeutic Interventions | 133 | ||
Education/Continuity of Care | 134 | ||
Impaired Physical Mobility | 134 | ||
Common Related Factors | 135 | ||
Defining Characteristics | 135 | ||
Common Expected Outcomes | 135 | ||
Ongoing Assessment | 135 | ||
Therapeutic Interventions | 137 | ||
Education/Continuity of Care | 138 | ||
Nausea | 139 | ||
Common Related Factors | 139 | ||
Defining Characteristics | 139 | ||
Common Expected Outcome | 140 | ||
Ongoing Assessment | 140 | ||
Therapeutic Interventions | 140 | ||
Education/Continuity of Care | 141 | ||
Noncompliance | 142 | ||
Common Related Factors | 142 | ||
Defining Characteristics | 142 | ||
Common Expected Outcomes | 142 | ||
Ongoing Assessment | 143 | ||
Therapeutic Interventions | 144 | ||
Education/Continuity of Care | 144 | ||
Imbalanced Nutrition: Less Than Body Requirements | 145 | ||
Common Related Factors | 145 | ||
Defining Characteristics | 145 | ||
Common Expected Outcomes | 145 | ||
Ongoing Assessment | 146 | ||
Therapeutic Interventions | 147 | ||
Education/Continuity of Care | 148 | ||
Overweight/Obesity | 148 | ||
Common Related Factors | 148 | ||
Defining Characteristics | 148 | ||
Common Expected Outcomes | 149 | ||
Ongoing Assessment | 149 | ||
Therapeutic Interventions | 150 | ||
Education/Continuity of Care | 150 | ||
Impaired Oral Mucous Membrane | 151 | ||
Common Related Factors | 151 | ||
Defining Characteristics | 151 | ||
Common Expected Outcomes | 152 | ||
Ongoing Assessment | 152 | ||
Therapeutic Interventions | 152 | ||
Education/Continuity of Care | 154 | ||
Acute Pain | 154 | ||
Common Related Factors | 155 | ||
Defining Characteristics | 155 | ||
Common Expected Outcomes | 155 | ||
Ongoing Assessment | 155 | ||
Therapeutic Interventions | 157 | ||
Education/Continuity of Care | 158 | ||
Chronic Pain | 159 | ||
Common Related Factors | 159 | ||
Defining Characteristics | 159 | ||
Common Expected Outcomes | 160 | ||
Ongoing Assessment | 160 | ||
Therapeutic Interventions | 161 | ||
Education/Continuity of Care | 161 | ||
Post-Trauma Syndrome | 163 | ||
Common Related Factors | 163 | ||
Defining Characteristics | 163 | ||
Common Expected Outcomes | 164 | ||
Ongoing Assessments | 164 | ||
Therapeutic Interventions | 165 | ||
Education/Continuity of Care | 165 | ||
Powerlessness | 166 | ||
Common Related Factors | 166 | ||
Defining Characteristics | 166 | ||
Common Expected Outcomes | 166 | ||
Ongoing Assessment | 167 | ||
Therapeutic Interventions | 167 | ||
Education/Continuity of Care | 168 | ||
Rape-Trauma Syndrome | 169 | ||
Common Related Factors | 169 | ||
Defining Characteristics | 169 | ||
Common Expected Outcomes | 169 | ||
Ongoing Assessment | 169 | ||
Therapeutic Interventions | 170 | ||
Education/Continuity of Care | 171 | ||
Relocation Stress Syndrome | 172 | ||
Common Related Factors | 172 | ||
Defining Characteristics | 172 | ||
Common Expected Outcomes | 173 | ||
Ongoing Assessments | 173 | ||
Therapeutic Interventions | 173 | ||
Education/Continuity of Care | 174 | ||
Self-Care Deficit: Bathing, Dressing, Feeding, Toileting, Transfer/Ambulation | 175 | ||
Common Related Factors | 175 | ||
Defining Characteristics | 175 | ||
Common Expected Outcomes | 176 | ||
Ongoing Assessment | 176 | ||
Therapeutic Interventions | 177 | ||
Education/Continuity of Care | 180 | ||
Situational Low Self-Esteem | 180 | ||
Common Related Factors | 180 | ||
Defining Characteristics | 180 | ||
Common Expected Outcomes | 180 | ||
Ongoing Assessment | 181 | ||
Therapeutic Interventions | 181 | ||
Education/Continuity of Care | 182 | ||
Ineffective Sexuality Pattern | 182 | ||
Common Related Factors | 183 | ||
Defining Characteristics | 183 | ||
Common Expected Outcomes | 183 | ||
Ongoing Assessment | 183 | ||
Therapeutic Interventions | 184 | ||
Education/Continuity of Care | 184 | ||
Risk for Impaired Skin Integrity | 185 | ||
Common Risk Factors | 186 | ||
Common Expected Outcome | 186 | ||
Ongoing Assessment | 186 | ||
Therapeutic Interventions | 188 | ||
Education/Continuity of Care | 189 | ||
Spiritual Distress | 190 | ||
Common Related Factors | 190 | ||
Defining Characteristics | 190 | ||
Common Expected Outcomes | 191 | ||
Ongoing Assessment | 191 | ||
Therapeutic Interventions | 191 | ||
Education/Continuity of Care | 192 | ||
Risk for Suicide | 192 | ||
Common Risk Factors | 193 | ||
Common Expected Outcomes | 193 | ||
Ongoing Assessment | 194 | ||
Therapeutic Interventions | 195 | ||
Education/Continuity of Care | 196 | ||
Impaired Swallowing | 196 | ||
Common Related Factors | 197 | ||
Defining Characteristics | 197 | ||
Common Expected Outcomes | 197 | ||
Ongoing Assessment | 197 | ||
Therapeutic Interventions | 197 | ||
Education/Continuity of Care | 199 | ||
Impaired Tissue Integrity | 200 | ||
Common Related Factors | 200 | ||
Defining Characteristics | 200 | ||
Common Expected Outcome | 200 | ||
Ongoing Assessment | 200 | ||
Therapeutic Interventions | 201 | ||
Education/Continuity of Care | 202 | ||
Ineffective Peripheral Tissue Perfusion | 202 | ||
Common Related Factors | 202 | ||
Defining Characteristics | 202 | ||
Common Expected Outcomes | 203 | ||
Ongoing Assessment | 203 | ||
Therapeutic Interventions | 203 | ||
Education/Continuity of Care | 204 | ||
Urinary Retention | 204 | ||
Common Related Factors | 205 | ||
Defining Characteristics | 205 | ||
Common Expected Outcome | 205 | ||
Ongoing Assessment | 205 | ||
Therapeutic Interventions | 206 | ||
Education/Continuity of Care | 206 | ||
Dysfunctional Ventilatory Weaning Response | 207.e1 | ||
Common Related Factors | 207.e1 | ||
Defining Characteristics | 207.e1 | ||
Common Expected Outcome | 207.e2 | ||
Ongoing Assessment | 207.e2 | ||
Therapeutic Interventions | 207.e3 | ||
Education/Continuity of Care | 207.e4 | ||
3 Health Promotion and Risk Factor Management Care Plans | 208 | ||
Health-Seeking Behaviors | 208 | ||
Common Related Factors | 209 | ||
Defining Characteristics | 209 | ||
Common Expected Outcomes | 209 | ||
Ongoing Assessment | 209 | ||
Therapeutic Interventions | 210 | ||
Education/Continuity of Care | 211 | ||
Readiness for Engaging in a Regular Physical Activity Program | 211 | ||
Defining Characteristics | 212 | ||
Common Expected Outcomes | 212 | ||
Ongoing Assessment | 212 | ||
Therapeutic Interventions | 213 | ||
Readiness for Enhanced Immunization Status | 215 | ||
Defining Characteristics | 216 | ||
Common Expected Outcomes | 216 | ||
Ongoing Assessment | 216 | ||
Therapeutic Interventions | 217 | ||
Readiness for Enhanced Nutrition | 219 | ||
Defining Characteristics | 219 | ||
Common Expected Outcomes | 220 | ||
Ongoing Assessment | 220 | ||
Therapeutic Interventions | 220 | ||
Readiness for Enhanced Sleep | 224 | ||
Defining Characteristics | 224 | ||
Common Expected Outcomes | 224 | ||
Ongoing Assessment | 225 | ||
Therapeutic Interventions | 225 | ||
Readiness for Managing Stress | 228 | ||
Defining Characteristics | 228 | ||
Common Expected Outcomes | 228 | ||
Ongoing Assessment | 228 | ||
Therapeutic Interventions | 229 | ||
Readiness for Smoking Cessation | 232 | ||
Defining Characteristics | 233 | ||
Common Expected Outcomes | 233 | ||
Ongoing Assessment | 233 | ||
Therapeutic Interventions | 234 | ||
Readiness for Weight Management | 237 | ||
Defining Characteristics | 237 | ||
Common Expected Outcomes | 238 | ||
Ongoing Assessment | 238 | ||
Therapeutic Interventions | 239 | ||
4 Basic Nursing Concepts Care Plans | 244 | ||
Surgical Experience: Preoperative and Postoperative Care | 244 | ||
Preoperative Phase | 245 | ||
Deficient Knowledge | 245 | ||
Common Related Factors | 245 | ||
Defining Characteristics | 245 | ||
Common Expected Outcomes | 245 | ||
Ongoing Assessment | 245 | ||
Therapeutic Interventions | 246 | ||
Anxiety | 249 | ||
Common Related Factors | 249 | ||
Defining Characteristics | 249 | ||
Common Expected Outcomes | 249 | ||
Ongoing Assessment | 249 | ||
Therapeutic Interventions | 250 | ||
Postoperative Phase | 251 | ||
Acute Pain | 251 | ||
Common Related Factors | 251 | ||
Defining Characteristics | 251 | ||
Common Expected Outcomes | 251 | ||
Ongoing Assessment | 251 | ||
Therapeutic Interventions | 252 | ||
Ineffective Breathing Pattern | 252 | ||
Common Related Factors | 252 | ||
Defining Characteristics | 252 | ||
Common Expected Outcome | 252 | ||
Ongoing Assessment | 252 | ||
Therapeutic Interventions | 253 | ||
Risk for Deficient Fluid Volume | 254 | ||
Common Risk Factors | 254 | ||
Common Expected Outcome | 254 | ||
Ongoing Assessment | 254 | ||
Therapeutic Interventions | 254 | ||
Risk for Infection | 255 | ||
Common Risk Factors | 255 | ||
Common Expected Outcomes | 255 | ||
Ongoing Assessment | 255 | ||
Therapeutic Interventions | 256 | ||
Risk for Impaired Abdominal Wound Healing | 257 | ||
Common Risk Factors | 257 | ||
Common Expected Outcome | 257 | ||
Ongoing Assessment | 257 | ||
Therapeutic Interventions | 258 | ||
Risk for Deep Vein Thrombosis | 258 | ||
Common Risk Factors | 258 | ||
Common Expected Outcome | 259 | ||
Ongoing Assessment | 259 | ||
Therapeutic Interventions | 259 | ||
Deficient Knowledge | 260 | ||
Common Related Factors | 260 | ||
Defining Characteristics | 260 | ||
Common Expected Outcome | 260 | ||
Ongoing Assessment | 260 | ||
Therapeutic Interventions | 260 | ||
Blood Component Therapy | 261 | ||
Deficient Knowledge | 262 | ||
Common Related Factors | 262 | ||
Defining Characteristics | 262 | ||
Common Expected Outcomes | 262 | ||
Ongoing Assessment | 262 | ||
Therapeutic Interventions | 263 | ||
Risk for Injury: Blood Transfusion Reaction | 263 | ||
Common Risk Factors | 263 | ||
Common Expected Outcome | 263 | ||
Ongoing Assessment | 263 | ||
Therapeutic Interventions | 265 | ||
Central Venous Access Devices | 266 | ||
Risk for Injury: Impaired Catheter Function | 267 | ||
Common Risk Factors | 267 | ||
Common Expected Outcome | 267 | ||
Ongoing Assessment | 267 | ||
Therapeutic Interventions | 267 | ||
Risk for Infection | 268 | ||
Common Risk Factors | 268 | ||
Common Expected Outcome | 268 | ||
Ongoing Assessment | 268 | ||
Therapeutic Interventions | 269 | ||
Deficient Knowledge | 269 | ||
Common Related Factors | 269 | ||
Defining Characteristics | 269 | ||
Common Expected Outcomes | 269 | ||
Ongoing Assessment | 270 | ||
Therapeutic Interventions | 270 | ||
Parenteral Nutrition | 271 | ||
Imbalanced Nutrition: Less Than Body Requirements | 271 | ||
Common Related Factors | 271 | ||
Defining Characteristics | 271 | ||
Common Expected Outcome | 271 | ||
Ongoing Assessment | 272 | ||
Therapeutic Interventions | 272 | ||
Risk for Deficient Fluid Volume | 273 | ||
Common Risk Factors | 273 | ||
Common Expected Outcome | 273 | ||
Ongoing Assessment | 273 | ||
Therapeutic Interventions | 273 | ||
Risk for Excess Fluid Volume | 274 | ||
Common Risk Factors | 274 | ||
Common Expected Outcome | 274 | ||
Ongoing Assessment | 274 | ||
Therapeutic Interventions | 274 | ||
Risk for Altered Body Composition | 275 | ||
Common Risk Factors | 275 | ||
Common Expected Outcomes | 275 | ||
Ongoing Assessment | 275 | ||
Therapeutic Interventions | 276 | ||
Enteral Nutrition | 276 | ||
Imbalanced Nutrition: Less Than Body Requirements | 277 | ||
Common Related Factor | 277 | ||
Defining Characteristics | 277 | ||
Common Expected Outcomes | 277 | ||
Ongoing Assessment | 277 | ||
Therapeutic Interventions | 277 | ||
Risk for Aspiration | 278 | ||
Common Risk Factors | 278 | ||
Common Expected Outcome | 278 | ||
Ongoing Assessment | 279 | ||
Therapeutic Interventions | 279 | ||
Risk for Diarrhea | 280 | ||
Common Risk Factor | 280 | ||
Common Expected Outcome | 280 | ||
Ongoing Assessment | 280 | ||
Therapeutic Interventions | 281 | ||
Deficient Knowledge | 281 | ||
Common Related Factors | 281 | ||
Defining Characteristics | 281 | ||
Common Expected Outcomes | 281 | ||
Ongoing Assessment | 282 | ||
Therapeutic Interventions | 282 | ||
Hearing Loss | 282 | ||
Impaired Verbal Communication | 283 | ||
Common Related Factors | 283 | ||
Defining Characteristics | 283 | ||
Common Expected Outcome | 283 | ||
Ongoing Assessment | 283 | ||
Therapeutic Interventions | 284 | ||
Deficient Knowledge | 285 | ||
Common Related Factors | 285 | ||
Defining Characteristics | 285 | ||
Common Expected Outcomes | 285 | ||
Ongoing Assessment | 285 | ||
Therapeutic Interventions | 285 | ||
Impaired Body Image | 286 | ||
Common Related Factors | 286 | ||
Defining Characteristics | 286 | ||
Common Expected Outcome | 286 | ||
Ongoing Assessment | 286 | ||
Therapeutic Interventions | 287 | ||
Visual Impairment | 287 | ||
Deficient Knowledge | 287 | ||
Common Related Factors | 287 | ||
Defining Characteristics | 287 | ||
Common Expected Outcome | 288 | ||
Ongoing Assessment | 288 | ||
Therapeutic Interventions | 288 | ||
Risk for Falls | 289 | ||
Common Risk Factors | 289 | ||
Common Expected Outcomes | 289 | ||
Ongoing Assessment | 289 | ||
Therapeutic Interventions | 290 | ||
Ineffective Coping | 290 | ||
Common Related Factors | 290 | ||
Defining Characteristics | 290 | ||
Common Expected Outcomes | 291 | ||
Ongoing Assessment | 291 | ||
Therapeutic Interventions | 291 | ||
Substance Use Disorders | 292 | ||
Deficient Knowledge | 293 | ||
Common Related Factors | 293 | ||
Defining Characteristics | 293 | ||
Common Expected Outcome | 293 | ||
Ongoing Assessment | 293 | ||
Therapeutic Interventions | 294 | ||
Noncompliance With Treatment Program | 295 | ||
Common Related Factors | 295 | ||
Defining Characteristics | 295 | ||
Common Expected Outcomes | 295 | ||
Ongoing Assessment | 296 | ||
Therapeutic Interventions | 296 | ||
Death and Dying: End-of-Life Issues | 297 | ||
Fear | 297 | ||
Common Related Factors | 297 | ||
Defining Characteristics | 297 | ||
Common Expected Outcomes | 297 | ||
Ongoing Assessment | 298 | ||
Therapeutic Interventions | 298 | ||
Grieving | 300 | ||
Common Related Factor | 300 | ||
Defining Characteristics | 300 | ||
Common Expected Outcomes | 300 | ||
Ongoing Assessment | 300 | ||
Therapeutic Interventions | 301 | ||
Powerlessness | 302 | ||
Common Related Factors | 302 | ||
Defining Characteristics | 302 | ||
Common Expected Outcomes | 302 | ||
Ongoing Assessment | 302 | ||
Therapeutic Interventions | 303 | ||
Spiritual Distress | 304 | ||
Common Related Factors | 304 | ||
Defining Characteristics | 304 | ||
Common Expected Outcomes | 304 | ||
Ongoing Assessment | 305 | ||
Therapeutic Interventions | 305 | ||
Common Mood Disorders: Depression and Bipolar Disorder | 305.e1 | ||
Deficient Knowledge | 305.e1 | ||
Common Related Factors | 305.e1 | ||
Defining Characteristics | 305.e1 | ||
Common Expected Outcome | 305.e1 | ||
Ongoing Assessment | 305.e2 | ||
Therapeutic Interventions | 305.e2 | ||
Impaired Social Interaction | 305.e4 | ||
Common Related Factors | 305.e4 | ||
Defining Characteristics | 305.e4 | ||
Common Expected Outcomes | 305.e4 | ||
Ongoing Assessment | 305.e5 | ||
Therapeutic Interventions | 305.e5 | ||
5 Cardiac and Vascular Care Plans | 306 | ||
Acute Coronary Syndromes/Myocardial Infarction: Unstable Angina; ST-Segment Elevation Myocardial Infarction; Non–ST-Segment Elevation Myocardial Infarction; | 306 | ||
Acute Pain | 307 | ||
Common Related Factors | 307 | ||
Defining Characteristics | 307 | ||
Common Expected Outcomes | 307 | ||
Ongoing Assessment | 307 | ||
Therapeutic Interventions | 309 | ||
Fear | 310 | ||
Common Related Factors | 310 | ||
Defining Characteristics | 310 | ||
Common Expected Outcomes | 310 | ||
Ongoing Assessment | 310 | ||
Therapeutic Interventions | 311 | ||
Risk for Decreased Cardiac Output | 311 | ||
Common Risk Factors | 311 | ||
Common Expected Outcome | 311 | ||
Ongoing Assessment | 312 | ||
Therapeutic Interventions | 312 | ||
Risk for Decreased Cardiac Output: Dysrhythmias | 313 | ||
Common Risk Factor | 313 | ||
Common Expected Outcome | 313 | ||
Ongoing Assessment | 313 | ||
Therapeutic Interventions | 314 | ||
Deficient Knowledge | 314 | ||
Common Related Factors | 314 | ||
Defining Characteristics | 314 | ||
Common Expected Outcome | 315 | ||
Ongoing Assessment | 315 | ||
Therapeutic Interventions | 315 | ||
Angina Pectoris, Stable: Chest Pain | 316 | ||
Acute Pain | 317 | ||
Common Related Factors | 317 | ||
Defining Characteristics | 317 | ||
Common Expected Outcomes | 317 | ||
Ongoing Assessment | 317 | ||
Therapeutic Interventions | 318 | ||
Deficient Knowledge | 318 | ||
Common Related Factors | 318 | ||
Defining Characteristics | 318 | ||
Common Expected Outcomes | 318 | ||
Ongoing Assessment | 318 | ||
Therapeutic Interventions | 319 | ||
Activity Intolerance | 321 | ||
Common Related Factors | 321 | ||
Defining Characteristics | 321 | ||
Common Expected Outcomes | 322 | ||
Ongoing Assessment | 322 | ||
Therapeutic Interventions | 322 | ||
Aortic Aneurysm: Abdominal Aneurysm; Thoracic Aneurysm; Dissecting Aneurysm | 322.e1 | ||
Risk for Ineffective Tissue Perfusion | 322.e1 | ||
Common Risk Factors | 322.e1 | ||
Common Expected Outcomes | 322.e1 | ||
Ongoing Assessment | 322.e2 | ||
Therapeutic Interventions | 322.e3 | ||
Risk for Decreased Cardiac Output | 322.e3 | ||
Common Risk Factors | 322.e3 | ||
Common Expected Outcome | 322.e3 | ||
Ongoing Assessment | 322.e4 | ||
Therapeutic Interventions | 322.e4 | ||
Anxiety | 322.e4 | ||
Common Related Factors | 322.e4 | ||
Defining Characteristics | 322.e4 | ||
Common Expected Outcomes | 322.e5 | ||
Ongoing Assessment | 322.e5 | ||
Therapeutic Interventions | 322.e5 | ||
Deficient Knowledge: Follow-Up Care | 322.e5 | ||
Common Related Factors | 322.e5 | ||
Defining Characteristics | 322.e5 | ||
Common Expected Outcome | 322.e5 | ||
Ongoing Assessment | 322.e6 | ||
Therapeutic Interventions | 322.e6 | ||
Atrial Fibrillation | 323 | ||
Deficient Knowledge | 323 | ||
Common Related Factors | 323 | ||
Defining Characteristics | 323 | ||
Common Expected Outcome | 323 | ||
Ongoing Assessment | 324 | ||
Therapeutic Interventions | 324 | ||
Risk for Ineffective Coping | 326 | ||
Common Risk Factors | 326 | ||
Common Expected Outcomes | 326 | ||
Ongoing Assessment | 326 | ||
Therapeutic Interventions | 326 | ||
Cardiac Rehabilitation: Post–Myocardial Infarction; Post–Cardiac Surgery; Post–Percutaneous Transluminal Coronary Angioplasty; Chronic Heart Failure; Stable Angina; Activity Progression; Cardiac Education | 327 | ||
Activity Intolerance | 328 | ||
Common Related Factors | 328 | ||
Defining Characteristics | 328 | ||
Common Expected Outcomes | 328 | ||
Ongoing Assessment | 328 | ||
Therapeutic Interventions | 329 | ||
Deficient Knowledge | 331 | ||
Common Related Factors | 331 | ||
Defining Characteristics | 331 | ||
Common Expected Outcomes | 331 | ||
Ongoing Assessment | 331 | ||
Therapeutic Interventions | 332 | ||
Risk for Ineffective Coping | 333 | ||
Common Risk Factors | 333 | ||
Common Expected Outcomes | 333 | ||
Ongoing Assessment | 333 | ||
Therapeutic Interventions | 333 | ||
Coronary Bypass/Valve Surgery: Postoperative Care: Coronary Artery Bypass Graft (CABG); Valve Replacement; Minimally Invasive Direct CAB (MIDCAB) Surgery; Off-Pump CABG (OPCAB) | 334 | ||
Coronary Bypass Surgery | 334 | ||
Valve Replacement Surgery | 335 | ||
Decreased Cardiac Output | 335 | ||
Common Related Factor | 335 | ||
Defining Characteristics | 335 | ||
Common Expected Outcome | 335 | ||
Ongoing Assessment | 336 | ||
Therapeutic Interventions | 337 | ||
Deficient Fluid Volume | 338 | ||
Common Related Factors | 338 | ||
Defining Characteristics | 338 | ||
Common Expected Outcome | 338 | ||
Ongoing Assessment | 338 | ||
Therapeutic Interventions | 339 | ||
Risk for Decreased Cardiac Output: Dysrhythmias | 339 | ||
Common Risk Factors | 339 | ||
Common Expected Outcome | 339 | ||
Ongoing Assessment | 339 | ||
Therapeutic Interventions | 340 | ||
Decreased Cardiac Output: Cardiac Tamponade | 340 | ||
Common Related Factor | 340 | ||
Defining Characteristics | 340 | ||
Common Expected Outcome | 341 | ||
Ongoing Assessment | 341 | ||
Therapeutic Interventions | 342 | ||
Risk for Ineffective Myocardial Tissue Perfusion | 342 | ||
Common Risk Factors | 342 | ||
Common Expected Outcome | 342 | ||
Ongoing Assessment | 342 | ||
6 Pulmonary Care Plans | 416 | ||
Acute Respiratory Distress Syndrome (ARDS): Acute Lung Injury; Noncardiogenic Pulmonary Edema; Stiff Lung; Wet Lung | 416 | ||
Ineffective Breathing Pattern | 417 | ||
Common Related Factors | 417 | ||
Defining Characteristics | 417 | ||
Common Expected Outcomes | 417 | ||
Ongoing Assessment | 417 | ||
Therapeutic Interventions | 418 | ||
Impaired Gas Exchange | 419 | ||
Common Related Factors | 419 | ||
Defining Characteristics | 419 | ||
Common Expected Outcome | 419 | ||
Ongoing Assessment | 419 | ||
Therapeutic Interventions | 420 | ||
Risk for Decreased Cardiac Output | 421 | ||
Common Risk Factors | 421 | ||
Common Expected Outcome | 422 | ||
Ongoing Assessment | 422 | ||
Therapeutic Interventions | 422 | ||
Risk for Ineffective Protection | 423 | ||
Common Risk Factors | 423 | ||
Common Expected Outcomes | 423 | ||
Ongoing Assessment | 423 | ||
Therapeutic Interventions | 424 | ||
Anxiety | 425 | ||
Common Related Factors | 425 | ||
Defining Characteristics | 425 | ||
Common Expected Outcomes | 425 | ||
Ongoing Assessment | 425 | ||
Therapeutic Interventions | 425 | ||
Asthma: Bronchial Asthma; Status Asthmaticus | 426 | ||
Ineffective Breathing Pattern | 427 | ||
Common Related Factor | 427 | ||
Defining Characteristics | 427 | ||
Common Expected Outcome | 427 | ||
Ongoing Assessment | 427 | ||
Therapeutic Interventions | 428 | ||
Ineffective Airway Clearance | 429 | ||
Common Related Factors | 429 | ||
Defining Characteristics | 429 | ||
Common Expected Outcome | 429 | ||
Ongoing Assessment | 429 | ||
Therapeutic Interventions | 430 | ||
Anxiety | 431 | ||
Common Related Factors | 431 | ||
Defining Characteristics | 431 | ||
Common Expected Outcomes | 431 | ||
Ongoing Assessment | 431 | ||
Therapeutic Interventions | 431 | ||
Deficient Knowledge | 432 | ||
Common Related Factors | 432 | ||
Defining Characteristics | 432 | ||
Common Expected Outcome | 432 | ||
Ongoing Assessment | 432 | ||
Therapeutic Interventions | 433 | ||
Chest Trauma: Pneumothorax; Tension Pneumothorax; Flail Chest; Fractured Ribs; Pulmonary Contusion; Hemothorax; Myocardial Contusion; Cardiac Tamponade | 434 | ||
Ineffective Breathing Pattern | 435 | ||
Common Related Factors | 435 | ||
Defining Characteristics | 435 | ||
Common Expected Outcome | 435 | ||
Ongoing Assessment | 435 | ||
Therapeutic Interventions | 436 | ||
Deficient Fluid Volume | 437 | ||
Common Related Factors | 437 | ||
Defining Characteristics | 437 | ||
Common Expected Outcome | 437 | ||
Ongoing Assessment | 438 | ||
Therapeutic Interventions | 438 | ||
Decreased Cardiac Output | 439 | ||
Related Factors | 439 | ||
Defining Characteristics | 439 | ||
Common Expected Outcome | 439 | ||
Ongoing Assessment | 440 | ||
Therapeutic Interventions | 441 | ||
Acute Pain | 441 | ||
Common Related Factors | 441 | ||
Defining Characteristics | 441 | ||
Common Expected Outcomes | 442 | ||
Ongoing Assessment | 442 | ||
Therapeutic Interventions | 442 | ||
Anxiety | 443 | ||
Common Related Factors | 443 | ||
Defining Characteristics | 443 | ||
Common Expected Outcomes | 443 | ||
Ongoing Assessment | 443 | ||
Therapeutic Interventions | 443 | ||
Chronic Obstructive Pulmonary Disease: Chronic Bronchitis; Emphysema | 444 | ||
Ineffective Airway Clearance | 444 | ||
Common Related Factors | 444 | ||
Defining Characteristics | 444 | ||
Common Expected Outcomes | 445 | ||
Ongoing Assessment | 445 | ||
Therapeutic Interventions | 446 | ||
Impaired Gas Exchange | 447 | ||
Common Related Factors | 447 | ||
Defining Characteristics | 447 | ||
Common Expected Outcome | 447 | ||
Ongoing Assessment | 447 | ||
Therapeutic Interventions | 448 | ||
Imbalanced Nutrition: Less Than Body Requirements | 449 | ||
Common Related Factors | 449 | ||
Defining Characteristics | 449 | ||
Common Expected Outcome | 449 | ||
Ongoing Assessment | 449 | ||
Therapeutic Interventions | 450 | ||
Risk for Infection | 450 | ||
Common Risk Factors | 450 | ||
Common Expected Outcome | 450 | ||
Ongoing Assessment | 450 | ||
Therapeutic Interventions | 451 | ||
Deficient Knowledge | 451 | ||
Common Related Factors | 451 | ||
Defining Characteristics | 451 | ||
Common Expected Outcome | 451 | ||
Ongoing Assessment | 452 | ||
Therapeutic Interventions | 452 | ||
Cystic Fibrosis | 454.e1 | ||
Infection | 454.e1 | ||
Common Related Factors | 454.e1 | ||
Defining Characteristics | 454.e1 | ||
Common Expected Outcome | 454.e1 | ||
Ongoing Assessment | 454.e2 | ||
Therapeutic Interventions | 454.e2 | ||
Ineffective Airway Clearance | 454.e3 | ||
Common Related Factor | 454.e3 | ||
Defining Characteristics | 454.e3 | ||
Common Expected Outcomes | 454.e3 | ||
Ongoing Assessment | 454.e3 | ||
Therapeutic Interventions | 454.e4 | ||
Impaired Gas Exchange | 454.e4 | ||
Common Related Factors | 454.e4 | ||
Defining Characteristics | 454.e4 | ||
Common Expected Outcome | 454.e4 | ||
Ongoing Assessment | 454.e5 | ||
Therapeutic Interventions | 454.e5 | ||
Imbalanced Nutrition: Less Than Body Requirements | 454.e5 | ||
Common Related Factors | 454.e5 | ||
Defining Characteristics | 454.e5 | ||
Common Expected Outcomes | 454.e5 | ||
Ongoing Assessment | 454.e6 | ||
Therapeutic Interventions | 454.e6 | ||
Deficient Knowledge | 454.e6 | ||
Common Related Factors | 454.e6 | ||
Defining Characteristics | 454.e6 | ||
Common Expected Outcome | 454.e7 | ||
Ongoing Assessment | 454.e7 | ||
Therapeutic Interventions | 454.e7 | ||
Drowning | 454.e8 | ||
Impaired Gas Exchange | 454.e9 | ||
Common Related Factors | 454.e9 | ||
Defining Characteristics | 454.e9 | ||
Common Expected Outcome | 454.e9 | ||
Ongoing Assessment | 454.e9 | ||
Therapeutic Interventions | 454.e10 | ||
Ineffective Cerebral Tissue Perfusion | 454.e10 | ||
Common Related Factors | 454.e10 | ||
Defining Characteristics | 454.e10 | ||
Common Expected Outcome | 454.e10 | ||
Ongoing Assessment | 454.e10 | ||
Therapeutic Interventions | 454.e11 | ||
Excess/Deficient Fluid Volume | 454.e11 | ||
Common Related Factors | 454.e11 | ||
Defining Characteristics | 454.e11 | ||
Common Expected Outcome | 454.e11 | ||
Ongoing Assessment | 454.e12 | ||
Therapeutic Interventions | 454.e12 | ||
Risk for Decreased Cardiac Output | 454.e13 | ||
Common Risk Factors | 454.e13 | ||
Common Expected Outcome | 454.e13 | ||
Ongoing Assessment | 454.e13 | ||
Therapeutic Interventions | 454.e13 | ||
Risk for Infection | 454.e14 | ||
Common Risk Factors | 454.e14 | ||
Common Expected Outcome | 454.e14 | ||
Ongoing Assessment | 454.e14 | ||
Therapeutic Interventions | 454.e15 | ||
Head and Neck Cancer: Surgical Approaches: Radical Neck Surgery; Laryngectomy | 454 | ||
Ineffective Airway Clearance | 454 | ||
Common Related Factors | 454 | ||
Defining Characteristics | 454 | ||
Common Expected Outcome | 455 | ||
Ongoing Assessment | 455 | ||
Therapeutic Interventions | 455 | ||
Impaired Verbal Communication | 456 | ||
Common Related Factors | 456 | ||
Defining Characteristics | 456 | ||
Common Expected Outcome | 456 | ||
Ongoing Assessment | 456 | ||
Therapeutic Interventions | 457 | ||
Risk for Ineffective Tissue Perfusion | 457 | ||
Common Risk Factors | 457 | ||
Common Expected Outcome | 458 | ||
Ongoing Assessment | 458 | ||
Therapeutic Interventions | 458 | ||
Imbalanced Nutrition: Less Than Body Requirements | 458 | ||
Common Related Factors | 458 | ||
Defining Characteristics | 458 | ||
Common Expected Outcomes | 459 | ||
Ongoing Assessment | 459 | ||
Therapeutic Interventions | 459 | ||
Disturbed Body Image | 460 | ||
Common Related Factors | 460 | ||
Defining Characteristics | 460 | ||
Common Expected Outcome | 460 | ||
Ongoing Assessment | 460 | ||
Therapeutic Interventions | 460 | ||
Deficient Knowledge: Preoperative and Postoperative | 461 | ||
Common Related Factors | 461 | ||
Defining Characteristics | 461 | ||
Common Expected Outcome | 461 | ||
Ongoing Assessment | 461 | ||
Therapeutic Interventions | 461 | ||
Lung Cancer: Squamous Cell Carcinoma; Small Cell Carcinoma; Non–Small Cell Carcinoma; Adenocarcinoma; Large Cell Tumors | 463 | ||
Deficient Knowledge | 463 | ||
Common Related Factors | 463 | ||
Defining Characteristics | 463 | ||
Common Expected Outcomes | 463 | ||
Ongoing Assessment | 464 | ||
Therapeutic Interventions | 464 | ||
Cancer-Related Fatigue | 467 | ||
Common Related Factors | 467 | ||
Defining Characteristics | 467 | ||
Common Expected Outcomes | 467 | ||
Ongoing Assessment | 467 | ||
Therapeutic Interventions | 468 | ||
Risk for Ineffective Protection | 468 | ||
Common Risk Factors | 468 | ||
Common Expected Outcome | 468 | ||
Ongoing Assessment | 469 | ||
Therapeutic Interventions | 469 | ||
Acute Pain | 470 | ||
Common Related Factors | 470 | ||
Defining Characteristics | 470 | ||
Common Expected Outcomes | 470 | ||
Ongoing Assessment | 470 | ||
Therapeutic Interventions | 471 | ||
Mechanical Ventilation: Ventilator; Endotracheal Tube; Intubation; Ventilator-Associated Pneumonia | 471 | ||
Impaired Spontaneous Ventilation | 472 | ||
Common Related Factors | 472 | ||
Defining Characteristics | 472 | ||
Common Expected Outcomes | 472 | ||
Ongoing Assessment | 472 | ||
Therapeutic Interventions | 473 | ||
Risk for Ineffective Protection | 475 | ||
Common Risk Factors | 475 | ||
Common Expected Outcomes | 475 | ||
Ongoing Assessment | 476 | ||
Therapeutic Interventions | 477 | ||
Ineffective Airway Clearance | 478 | ||
Common Related Factors | 478 | ||
Defining Characteristics | 478 | ||
Common Expected Outcome | 478 | ||
Ongoing Assessment | 478 | ||
Therapeutic Interventions | 478 | ||
Risk for Decreased Cardiac Output | 479 | ||
Common Risk Factors | 479 | ||
Common Expected Outcome | 479 | ||
Ongoing Assessment | 479 | ||
Therapeutic Interventions | 480 | ||
Anxiety | 480 | ||
Common Related Factors | 480 | ||
Defining Characteristics | 480 | ||
Common Expected Outcomes | 480 | ||
Ongoing Assessment | 481 | ||
Therapeutic Interventions | 481 | ||
Deficient Knowledge | 481 | ||
Common Related Factors | 481 | ||
Defining Characteristics | 481 | ||
Common Expected Outcome | 481 | ||
Ongoing Assessment | 482 | ||
Therapeutic Interventions | 482 | ||
Obstructive Sleep Apnea: Sleep-Disordered Breathing | 483 | ||
Ineffective Breathing Pattern | 483 | ||
Common Related Factors | 483 | ||
Defining Characteristics | 483 | ||
Common Expected Outcomes | 483 | ||
Ongoing Assessment | 483 | ||
Therapeutic Interventions | 484 | ||
Sleep Deprivation | 486 | ||
Common Related Factors | 486 | ||
Defining Characteristics | 486 | ||
Common Expected Outcome | 486 | ||
Ongoing Assessment | 486 | ||
Therapeutic Interventions | 487 | ||
Pneumonia: Pneumonitis; Community-Acquired Pneumonia (CAP); Hospital-Acquired Pneumonia (HAP); Aspiration Pneumonia | 488 | ||
Infection | 488 | ||
Common Related Factor | 488 | ||
Defining Characteristics | 488 | ||
Common Expected Outcomes | 488 | ||
Ongoing Assessment | 489 | ||
Therapeutic Interventions | 490 | ||
Ineffective Airway Clearance | 490 | ||
Common Related Factors | 490 | ||
Defining Characteristics | 490 | ||
Common Expected Outcome | 491 | ||
Ongoing Assessment | 491 | ||
Therapeutic Interventions | 491 | ||
Impaired Gas Exchange | 492 | ||
Common Related Factors | 492 | ||
Defining Characteristics | 492 | ||
Common Expected Outcome | 492 | ||
Ongoing Assessment | 493 | ||
Therapeutic Interventions | 493 | ||
Acute Pain | 494 | ||
Common Related Factors | 494 | ||
Defining Characteristics | 494 | ||
Common Expected Outcomes | 494 | ||
Ongoing Assessment | 494 | ||
Therapeutic Interventions | 494 | ||
Deficient Knowledge | 495 | ||
Common Related Factors | 495 | ||
Defining Characteristics | 495 | ||
Common Expected Outcome | 495 | ||
Ongoing Assessment | 495 | ||
Therapeutic Interventions | 495 | ||
Pneumothorax With Chest Tube: Collapsed Lung; Tension Pneumothorax | 496.e1 | ||
Ineffective Breathing Pattern | 496.e1 | ||
Common Related Factors | 496.e1 | ||
Defining Characteristics | 496.e1 | ||
Common Expected Outcome | 496.e1 | ||
Ongoing Assessment | 496.e1 | ||
Therapeutic Interventions | 496.e2 | ||
Deficient Knowledge | 496.e3 | ||
Common Related Factors | 496.e3 | ||
Defining Characteristics | 496.e3 | ||
Common Expected Outcome | 496.e3 | ||
Ongoing Assessment | 496.e3 | ||
Therapeutic Interventions | 496.e3 | ||
Pulmonary Embolism: Thromboembolism (VTE); Deep Vein Thrombosis (DVT) | 496 | ||
Ineffective Breathing Pattern | 496 | ||
Common Related Factors | 496 | ||
Defining Characteristics | 496 | ||
Common Expected Outcome | 496 | ||
Ongoing Assessment | 497 | ||
Therapeutic Interventions | 497 | ||
Impaired Gas Exchange | 498 | ||
Common Related Factors | 498 | ||
Defining Characteristics | 498 | ||
Common Expected Outcome | 498 | ||
Ongoing Assessment | 498 | ||
Therapeutic Interventions | 499 | ||
Risk for Bleeding | 499 | ||
Common Risk Factors | 499 | ||
Common Expected Outcomes | 499 | ||
Ongoing Assessment | 500 | ||
Therapeutic Interventions | 500 | ||
Deficient Knowledge | 501 | ||
Common Related Factors | 501 | ||
Defining Characteristics | 501 | ||
Common Expected Outcome | 501 | ||
Ongoing Assessment | 502 | ||
Therapeutic Interventions | 502 | ||
Pulmonary Tuberculosis: TB; Mycobacterium Tuberculosis | 503.e1 | ||
Infection | 503.e1 | ||
Common Related Factor | 503.e1 | ||
Defining Characteristics | 503.e1 | ||
Common Expected Outcomes | 503.e1 | ||
Ongoing Assessment | 503.e1 | ||
Therapeutic Interventions | 503.e2 | ||
Ineffective Breathing Pattern | 503.e4 | ||
Common Related Factors | 503.e4 | ||
Defining Characteristics | 503.e4 | ||
Common Expected Outcome | 503.e4 | ||
Ongoing Assessment | 503.e4 | ||
Therapeutic Interventions | 503.e4 | ||
Ineffective Health Management | 503.e5 | ||
Common Related Factors | 503.e5 | ||
Defining Characteristics | 503.e5 | ||
Common Expected Outcomes | 503.e5 | ||
Ongoing Assessment | 503.e5 | ||
Therapeutic Interventions | 503.e6 | ||
Respiratory Failure, Acute: Ventilatory Failure; Oxygenation Failure | 503 | ||
Impaired Spontaneous Ventilation | 503 | ||
Common Related Factors | 503 | ||
Defining Characteristics | 503 | ||
Common Expected Outcome | 503 | ||
Ongoing Assessment | 504 | ||
Therapeutic Interventions | 504 | ||
Risk for Ineffective Airway Clearance | 505 | ||
Common Risk Factors | 505 | ||
Common Expected Outcome | 505 | ||
Ongoing Assessment | 505 | ||
Therapeutic Interventions | 505 | ||
Risk for Infection | 506 | ||
Common Risk Factors | 506 | ||
Common Expected Outcome | 506 | ||
Ongoing Assessment | 506 | ||
Therapeutic Interventions | 506 | ||
Anxiety | 507 | ||
Common Related Factors | 507 | ||
Defining Characteristics | 507 | ||
Common Expected Outcomes | 507 | ||
Ongoing Assessment | 507 | ||
Therapeutic Interventions | 508 | ||
Deficient Knowledge | 508 | ||
Common Related Factors | 508 | ||
Defining Characteristics | 508 | ||
Common Expected Outcome | 508 | ||
Ongoing Assessment | 508 | ||
Therapeutic Interventions | 509 | ||
Thoracotomy: Chest Surgery; Thoracic Surgery; Lobectomy; Segmental Resection; Wedge Resection; Thoracostomy; Pneumonectomy | 509.e1 | ||
Ineffective Breathing Pattern | 509.e1 | ||
Common Related Factors | 509.e1 | ||
Defining Characteristics | 509.e1 | ||
Common Expected Outcome | 509.e1 | ||
Ongoing Assessment | 509.e1 | ||
Therapeutic Interventions | 509.e3 | ||
Ineffective Airway Clearance | 509.e3 | ||
Common Related Factors | 509.e3 | ||
Defining Characteristics | 509.e3 | ||
Common Expected Outcome | 509.e3 | ||
Ongoing Assessment | 509.e4 | ||
Therapeutic Interventions | 509.e4 | ||
Acute Pain | 509.e5 | ||
Common Related Factors | 509.e5 | ||
Defining Characteristics | 509.e5 | ||
Common Expected Outcomes | 509.e5 | ||
Ongoing Assessment | 509.e5 | ||
Therapeutic Interventions | 509.e5 | ||
Deficient Knowledge | 509.e6 | ||
Common Related Factors | 509.e6 | ||
Defining Characteristics | 509.e6 | ||
Common Expected Outcome | 509.e6 | ||
Ongoing Assessment | 509.e6 | ||
Therapeutic Interventions | 509.e6 | ||
Tracheostomy: Artificial Airway; Tracheotomy; Stoma | 509.e7 | ||
Ineffective Airway Clearance | 509.e8 | ||
Common Related Factors | 509.e8 | ||
Defining Characteristics | 509.e8 | ||
Common Expected Outcome | 509.e8 | ||
Ongoing Assessment | 509.e8 | ||
Therapeutic Interventions | 509.e8 | ||
Risk for Impaired Gas Exchange | 509.e9 | ||
Common Risk Factors | 509.e9 | ||
Common Expected Outcome | 509.e9 | ||
Ongoing Assessment | 509.e9 | ||
Therapeutic Interventions | 509.e10 | ||
Risk for Infection | 509.e10 | ||
Common Risk Factors | 509.e10 | ||
Common Expected Outcomes | 509.e11 | ||
Ongoing Assessment | 509.e11 | ||
Therapeutic Interventions | 509.e11 | ||
Impaired Verbal Communication | 509.e12 | ||
Common Related Factor | 509.e12 | ||
Defining Characteristics | 509.e12 | ||
Common Expected Outcome | 509.e12 | ||
Ongoing Assessment | 509.e12 | ||
Therapeutic Interventions | 509.e12 | ||
Deficient Knowledge | 509.e13 | ||
Common Related Factors | 509.e13 | ||
Defining Characteristics | 509.e13 | ||
Common Expected Outcome | 509.e13 | ||
Ongoing Assessment | 509.e13 | ||
Therapeutic Interventions | 509.e13 | ||
7 Neurological Care Plans | 510 | ||
Alzheimer’s Disease/Dementia: Multi-Infarct Dementia (MID); Dementia of the Alzheimer Type (DAT) | 510 | ||
Risk for Violence: Self-Directed or Other-Directed | 510 | ||
Common Risk Factors | 510 | ||
Common Expected Outcomes | 511 | ||
Ongoing Assessment | 511 | ||
Therapeutic Interventions | 511 | ||
Self-Care Deficit: Bathing, Dressing, Feeding | 513 | ||
Common Related Factors | 513 | ||
Defining Characteristics | 513 | ||
Common Expected Outcome | 513 | ||
Ongoing Assessment | 513 | ||
Therapeutic Interventions | 514 | ||
Impaired Social Interaction | 514 | ||
Common Related Factors | 514 | ||
Defining Characteristics | 514 | ||
Common Expected Outcome | 515 | ||
Ongoing Assessment | 515 | ||
Therapeutic Interventions | 515 | ||
Impaired Home Maintenance | 516 | ||
Common Related Factors | 516 | ||
Defining Characteristics | 516 | ||
Common Expected Outcomes | 516 | ||
Ongoing Assessment | 516 | ||
Therapeutic Interventions | 517 | ||
Caregiver Role Strain | 517 | ||
Common Related Factors | 517 | ||
Defining Characteristics | 517 | ||
Common Expected Outcomes | 517 | ||
Ongoing Assessment | 518 | ||
Therapeutic Interventions | 518 | ||
Amyotrophic Lateral Sclerosis: Lou Gehrig’s Disease; Motor Neuron Disease; Progressive Bulbar Palsy; Progressive Muscular Atrophy | 519.e1 | ||
Anxiety | 519.e1 | ||
Common Related Factors | 519.e1 | ||
Defining Characteristics | 519.e1 | ||
Common Expected Outcomes | 519.e1 | ||
Ongoing Assessment | 519.e2 | ||
Therapeutic Interventions | 519.e2 | ||
Ineffective Airway Clearance | 519.e3 | ||
Common Related Factors | 519.e3 | ||
Defining Characteristics | 519.e3 | ||
Common Expected Outcome | 519.e3 | ||
Ongoing Assessment | 519.e3 | ||
Therapeutic Interventions | 519.e4 | ||
Impaired Physical Mobility | 519.e5 | ||
Common Related Factors | 519.e5 | ||
Defining Characteristics | 519.e5 | ||
Common Expected Outcomes | 519.e5 | ||
Ongoing Assessment | 519.e5 | ||
Therapeutic Interventions | 519.e5 | ||
Imbalanced Nutrition: Less Than Body Requirements | 519.e6 | ||
Common Related Factors | 519.e6 | ||
Defining Characteristics | 519.e6 | ||
Common Expected Outcomes | 519.e6 | ||
Ongoing Assessment | 519.e6 | ||
Therapeutic Interventions | 519.e7 | ||
Impaired Verbal Communication | 519.e8 | ||
Common Related Factors | 519.e8 | ||
Defining Characteristics | 519.e8 | ||
Common Expected Outcome | 519.e8 | ||
Ongoing Assessment | 519.e8 | ||
Therapeutic Interventions | 519.e8 | ||
Deficient Knowledge | 519.e9 | ||
Common Related Factors | 519.e9 | ||
Defining Characteristics | 519.e9 | ||
Common Expected Outcome | 519.e9 | ||
Ongoing Assessment | 519.e9 | ||
Therapeutic Interventions | 519.e10 | ||
Carpal Tunnel Syndrome: Repetitive Stress Injury; Median Nerve Compression | 519.e11 | ||
Acute Pain | 519.e11 | ||
Common Related Factors | 519.e11 | ||
Defining Characteristics | 519.e11 | ||
Common Expected Outcomes | 519.e11 | ||
Ongoing Assessment | 519.e12 | ||
Therapeutic Interventions | 519.e12 | ||
Deficient Knowledge | 519.e13 | ||
Common Related Factors | 519.e13 | ||
Defining Characteristics | 519.e13 | ||
Common Expected Outcome | 519.e13 | ||
Ongoing Assessment | 519.e13 | ||
Therapeutic Interventions | 519.e13 | ||
Craniotomy: Craniectomy; Burr Hole; Cranioplasty; Cranial Surgery; Stereotactic Surgery | 519.e14 | ||
Decreased Intracranial Adaptive Capacity | 519.e14 | ||
Common Related Factors | 519.e14 | ||
Defining Characteristics | 519.e14 | ||
Common Expected Outcome | 519.e15 | ||
Ongoing Assessment | 519.e15 | ||
Therapeutic Interventions | 519.e16 | ||
Risk for Deficient Fluid Volume | 519.e17 | ||
Common Risk Factors | 519.e17 | ||
Common Expected Outcome | 519.e17 | ||
Ongoing Assessment | 519.e17 | ||
Therapeutic Interventions | 519.e17 | ||
Risk for Excess Fluid Volume | 519.e18 | ||
Common Risk Factor | 519.e18 | ||
Common Expected Outcome | 519.e18 | ||
Ongoing Assessment | 519.e18 | ||
Therapeutic Interventions | 519.e18 | ||
Risk for Seizures | 519.e18 | ||
Common Risk Factors | 519.e18 | ||
Common Expected Outcomes | 519.e19 | ||
Ongoing Assessment | 519.e19 | ||
Therapeutic Interventions | 519.e19 | ||
Deficient Knowledge | 519.e20 | ||
Common Related Factors | 519.e20 | ||
Defining Characteristics | 519.e20 | ||
Common Expected Outcomes | 519.e20 | ||
Ongoing Assessment | 519.e20 | ||
Therapeutic Interventions | 519.e20 | ||
Headache: Migraine, Cluster, Tension | 519 | ||
Deficient Knowledge | 520 | ||
Common Related Factors | 520 | ||
Defining Characteristics | 520 | ||
Common Expected Outcomes | 520 | ||
Ongoing Assessment | 520 | ||
Therapeutic Interventions | 521 | ||
Acute Pain | 522 | ||
Common Related Factor | 522 | ||
Defining Characteristics | 522 | ||
Common Expected Outcomes | 522 | ||
Ongoing Assessment | 522 | ||
Therapeutic Interventions | 523 | ||
Intracranial Infection: Meningitis; Encephalitis; Brain Abscess | 524.e1 | ||
Infection | 524.e1 | ||
Common Related Factors | 524.e1 | ||
Defining Characteristics | 524.e1 | ||
Common Expected Outcome | 524.e1 | ||
Ongoing Assessment | 524.e2 | ||
Therapeutic Interventions | 524.e2 | ||
Risk for Injury: Seizures | 524.e3 | ||
Common Risk Factors | 524.e3 | ||
Common Expected Outcomes | 524.e3 | ||
Ongoing Assessment | 524.e3 | ||
Therapeutic Interventions | 524.e3 | ||
Acute Pain | 524.e4 | ||
Common Related Factors | 524.e4 | ||
Defining Characteristics | 524.e4 | ||
Common Expected Outcomes | 524.e4 | ||
Ongoing Assessment | 524.e4 | ||
Therapeutic Interventions | 524.e4 | ||
Deficient Knowledge | 524.e5 | ||
Common Related Factors | 524.e5 | ||
Defining Characteristics | 524.e5 | ||
Common Expected Outcomes | 524.e5 | ||
Ongoing Assessment | 524.e5 | ||
Therapeutic Interventions | 524.e5 | ||
Intervertebral Disk Disease: Low Back Pain, Herniated Disk; Slipped Disk; Ruptured Disk; Sciatica; Laminectomy | 524 | ||
Acute Pain | 524 | ||
Common Related Factor | 524 | ||
Defining Characteristics | 524 | ||
Common Expected Outcomes | 524 | ||
Ongoing Assessment | 525 | ||
Therapeutic Interventions | 525 | ||
Deficient Knowledge | 526 | ||
Common Related Factors | 526 | ||
Defining Characteristics | 526 | ||
Common Expected Outcome | 526 | ||
Ongoing Assessment | 526 | ||
Therapeutic Interventions | 527 | ||
Lyme Disease | 528.e1 | ||
Deficient Knowledge | 528.e1 | ||
Common Related Factors | 528.e1 | ||
Defining Characteristics | 528.e1 | ||
Common Expected Outcome | 528.e1 | ||
Ongoing Assessment | 528.e1 | ||
Therapeutic Interventions | 528.e2 | ||
Infection | 528.e3 | ||
Common Related Factor | 528.e3 | ||
Defining Characteristics | 528.e3 | ||
Common Expected Outcome | 528.e3 | ||
Ongoing Assessment | 528.e3 | ||
Therapeutic Interventions | 528.e3 | ||
Multiple Sclerosis: Disseminated Sclerosis; Demyelinating Disease | 528 | ||
Deficient Knowledge | 528 | ||
Common Related Factors | 528 | ||
Defining Characteristics | 528 | ||
Common Expected Outcome | 529 | ||
Ongoing Assessment | 529 | ||
Therapeutic Interventions | 529 | ||
Impaired Physical Mobility | 531 | ||
Common Related Factors | 531 | ||
Defining Characteristics | 531 | ||
Common Expected Outcomes | 531 | ||
Ongoing Assessment | 531 | ||
Therapeutic Interventions | 532 | ||
Risk for Impaired Vision | 532 | ||
Common Risk Factor | 532 | ||
Common Expected Outcome | 532 | ||
Ongoing Assessment | 532 | ||
Therapeutic Interventions | 533 | ||
Risk for Urinary Retention/Incontinence | 533 | ||
Common Risk Factor | 533 | ||
Common Expected Outcomes | 533 | ||
Ongoing Assessment | 533 | ||
Therapeutic Interventions | 534 | ||
Risk for Falls | 534 | ||
Common Risk Factors | 534 | ||
Common Expected Outcomes | 534 | ||
Ongoing Assessment | 535 | ||
Therapeutic Interventions | 535 | ||
Myasthenia Gravis: Myasthenic Crisis; Cholinergic Crisis | 535.e1 | ||
Deficient Knowledge | 535.e1 | ||
Common Related Factors | 535.e1 | ||
Defining Characteristics | 535.e1 | ||
Common Expected Outcome | 535.e1 | ||
Ongoing Assessment | 535.e2 | ||
Therapeutic Interventions | 535.e2 | ||
Risk for Aspiration | 535.e3 | ||
Common Risk Factors | 535.e3 | ||
Common Expected Outcomes | 535.e4 | ||
Ongoing Assessment | 535.e4 | ||
Therapeutic Interventions | 535.e4 | ||
Risk for Imbalanced Nutrition: Less Than Body Requirements | 535.e5 | ||
Common Risk Factors | 535.e5 | ||
Common Expected Outcomes | 535.e5 | ||
Ongoing Assessment | 535.e6 | ||
Therapeutic Interventions | 535.e6 | ||
Ineffective Health Management | 535.e7 | ||
Common Related Factors | 535.e7 | ||
Defining Characteristics | 535.e7 | ||
Common Expected Outcomes | 535.e7 | ||
Ongoing Assessment | 535.e7 | ||
Therapeutic Interventions | 535.e7 | ||
Parkinson’s Disease: Parkinsonism | 536 | ||
Impaired Physical Mobility | 536 | ||
Common Related Factors | 536 | ||
Defining Characteristics | 536 | ||
Common Expected Outcomes | 536 | ||
Ongoing Assessment | 536 | ||
Therapeutic Interventions | 537 | ||
Imbalanced Nutrition: Less Than Body Requirements | 538 | ||
Common Related Factors | 538 | ||
Defining Characteristics | 538 | ||
Common Expected Outcomes | 538 | ||
Ongoing Assessment | 538 | ||
Therapeutic Interventions | 539 | ||
Impaired Verbal Communication | 539 | ||
Common Related Factor | 539 | ||
Defining Characteristics | 539 | ||
Common Expected Outcome | 539 | ||
Ongoing Assessment | 540 | ||
Therapeutic Interventions | 540 | ||
Chronic Low Self-Esteem | 540 | ||
Common Related Factors | 540 | ||
Defining Characteristics | 540 | ||
Common Expected Outcomes | 540 | ||
Ongoing Assessment | 541 | ||
Therapeutic Interventions | 541 | ||
Deficient Knowledge | 542 | ||
Common Related Factors | 542 | ||
Defining Characteristics | 542 | ||
Common Expected Outcome | 542 | ||
Ongoing Assessment | 542 | ||
Therapeutic Interventions | 542 | ||
Seizure Activity: Epilepsy; Seizure Disorder; Convulsion | 544 | ||
Deficient Knowledge | 544 | ||
Common Related Factors | 544 | ||
Defining Characteristics | 544 | ||
Common Expected Outcome | 545 | ||
Ongoing Assessment | 545 | ||
Therapeutic Interventions | 545 | ||
Risk for Chronic Low Self-Esteem | 548 | ||
Common Risk Factors | 548 | ||
Common Expected Outcome | 548 | ||
Ongoing Assessment | 548 | ||
Therapeutic Interventions | 548 | ||
Spinal Cord Injury: Tetraplegia; Quadriplegia; Paraplegia; Neurogenic Shock; Spinal Shock | 549 | ||
Risk for Ineffective Breathing Pattern | 549 | ||
Common Risk Factors | 549 | ||
Common Expected Outcome | 550 | ||
Ongoing Assessment | 550 | ||
Therapeutic Interventions | 550 | ||
Risk for Decreased Cardiac Output | 551 | ||
Common Risk Factors | 551 | ||
Common Expected Outcome | 551 | ||
Ongoing Assessment | 551 | ||
Therapeutic Interventions | 552 | ||
Impaired Physical Mobility | 552 | ||
Common Related Factors | 552 | ||
Defining Characteristics | 552 | ||
Common Expected Outcomes | 552 | ||
Ongoing Assessment | 553 | ||
Therapeutic Interventions | 553 | ||
Risk for Impaired Skin Integrity | 554 | ||
Common Risk Factors | 554 | ||
Common Expected Outcome | 554 | ||
Ongoing Assessment | 555 | ||
Therapeutic Interventions | 555 | ||
Disturbed Body Image | 556 | ||
Common Related Factors | 556 | ||
Defining Characteristics | 556 | ||
Common Expected Outcome | 556 | ||
Ongoing Assessment | 556 | ||
Therapeutic Interventions | 557 | ||
Deficient Knowledge | 557 | ||
Common Related Factors | 557 | ||
Defining Characteristics | 557 | ||
Common Expected Outcome | 557 | ||
Ongoing Assessment | 557 | ||
Therapeutic Interventions | 558 | ||
Stroke: Brain Attack; Cerebrovascular Accident (CVA); Ischemic Stroke; Thrombotic Stroke; Embolic Stroke; Hemorrhagic Stroke | 559 | ||
Impaired Cerebral Tissue Perfusion | 559 | ||
Common Related Factors | 559 | ||
Defining Characteristics | 559 | ||
Common Expected Outcome | 560 | ||
Ongoing Assessment | 560 | ||
Therapeutic Interventions | 561 | ||
Risk for Ineffective Airway Clearance | 561 | ||
Common Risk Factors | 561 | ||
Common Expected Outcome | 561 | ||
Ongoing Assessment | 562 | ||
Therapeutic Interventions | 562 | ||
Impaired Physical Mobility | 563 | ||
Common Related Factors | 563 | ||
Defining Characteristics | 563 | ||
Common Expected Outcomes | 563 | ||
Ongoing Assessment | 563 | ||
Therapeutic Interventions | 564 | ||
Risk for Impaired Verbal Communication | 566 | ||
Common Risk Factors | 566 | ||
Common Expected Outcome | 566 | ||
Ongoing Assessment | 566 | ||
Therapeutic Interventions | 566 | ||
Risk for Disturbed Sensory Perception (Tactile) | 567 | ||
Common Risk Factor | 567 | ||
Common Expected Outcome | 567 | ||
Ongoing Assessment | 567 | ||
Therapeutic Interventions | 568 | ||
Risk for Unilateral Neglect | 568 | ||
Common Risk Factor | 568 | ||
Common Expected Outcomes | 568 | ||
Ongoing Assessment | 569 | ||
Therapeutic Interventions | 569 | ||
Deficient Knowledge | 570 | ||
Common Related Factors | 570 | ||
Defining Characteristics | 570 | ||
Common Expected Outcome | 570 | ||
Ongoing Assessment | 570 | ||
Therapeutic Interventions | 570 | ||
Transient Ischemic Attack: Transient Ischemic Attack (TIA); Carotid Endarterectomy; Carotid Artery Stent | 571.e1 | ||
Deficient Knowledge | 571.e1 | ||
Common Related Factors | 571.e1 | ||
Defining Characteristics | 571.e1 | ||
Common Expected Outcome | 571.e1 | ||
Ongoing Assessment | 571.e1 | ||
Therapeutic Interventions | 571.e2 | ||
Risk for Ineffective Cerebral Tissue Perfusion | 571.e3 | ||
Common Risk Factors | 571.e3 | ||
Common Expected Outcome | 571.e3 | ||
Ongoing Assessment | 571.e3 | ||
Therapeutic Interventions | 571.e4 | ||
Traumatic Brain Injury: Head Trauma; Closed Head Trauma; Skull Fracture; Subdural Hematoma; Concussion | 572 | ||
Decreased Intracranial Adaptive Capacity | 572 | ||
Common Related Factors | 572 | ||
Defining Characteristics | 572 | ||
Common Expected Outcome | 572 | ||
Ongoing Assessment | 573 | ||
Therapeutic Interventions | 574 | ||
Risk for Deficient Fluid Volume | 574 | ||
Common Risk Factors | 574 | ||
Common Expected Outcome | 574 | ||
Ongoing Assessment | 575 | ||
Therapeutic Interventions | 575 | ||
Risk for Excess Fluid Volume | 575 | ||
Common Risk Factor | 575 | ||
Common Expected Outcome | 575 | ||
Ongoing Assessment | 576 | ||
Therapeutic Interventions | 576 | ||
Risk for Seizures | 576 | ||
Common Risk Factors | 576 | ||
Common Expected Outcomes | 576 | ||
8 Gastrointestinal and Digestive Care Plans | 581 | ||
Bariatric Surgery: Overweight; Obesity; Gastric Banding; Gastric Bypass | 581 | ||
Deficient Knowledge | 581 | ||
Common Related Factors | 581 | ||
Defining Characteristics | 581 | ||
Common Expected Outcomes | 581 | ||
Ongoing Assessment | 582 | ||
Therapeutic Interventions | 582 | ||
Risk for Imbalanced Nutrition: Less Than Body Requirements (Postoperative) | 584 | ||
Common Risk Factors | 584 | ||
Common Expected Outcomes | 584 | ||
Ongoing Assessment | 584 | ||
Therapeutic Interventions | 584 | ||
Risk for Disturbed Body Image | 585 | ||
Common Risk Factors | 585 | ||
Common Expected Outcome | 585 | ||
Ongoing Assessment | 585 | ||
Therapeutic Interventions | 585 | ||
Risk for Deficient Fluid Volume | 586 | ||
Common Risk Factor | 586 | ||
Common Expected Outcome | 586 | ||
Ongoing Assessment | 586 | ||
Therapeutic Interventions | 587 | ||
Risk for Ineffective Health Management | 587 | ||
Common Risk Factors | 587 | ||
Common Expected Outcomes | 587 | ||
Ongoing Assessment | 587 | ||
Therapeutic Interventions | 588 | ||
Bowel Diversion Surgery: Colostomy, Ileostomy: Fecal Diversion; Stoma | 590 | ||
Deficient Knowledge: Surgical Procedure | 590 | ||
Common Related Factors | 590 | ||
Defining Characteristics | 590 | ||
Common Expected Outcomes | 590 | ||
Ongoing Assessment | 590 | ||
Therapeutic Interventions | 591 | ||
Risk for Toileting Self-Care Deficit | 591 | ||
Common Risk Factors | 591 | ||
Common Expected Outcome | 591 | ||
Ongoing Assessment | 592 | ||
Therapeutic Interventions | 592 | ||
Risk for Ineffective Stoma Tissue Perfusion | 592 | ||
Common Risk Factor | 592 | ||
Common Expected Outcome | 592 | ||
Ongoing Assessment | 593 | ||
Therapeutic Interventions | 593 | ||
Risk for Impaired Skin Integrity | 593 | ||
Common Related Factors | 593 | ||
Defining Characteristics | 593 | ||
Common Expected Outcomes | 593 | ||
Ongoing Assessment | 594 | ||
Therapeutic Interventions | 594 | ||
Risk for Disturbed Body Image | 594 | ||
Common Risk Factors | 594 | ||
Common Expected Outcome | 594 | ||
Ongoing Assessment | 595 | ||
Therapeutic Interventions | 595 | ||
Deficient Knowledge: Stoma Care | 595 | ||
Common Related Factors | 595 | ||
Defining Characteristics | 595 | ||
Common Expected Outcomes | 596 | ||
Ongoing Assessment | 596 | ||
Therapeutic Interventions | 596 | ||
Cholecystectomy: Laparoscopic/Open, Postoperative Care | 597 | ||
Risk for Infection | 598 | ||
Common Risk Factor | 598 | ||
Common Expected Outcomes | 598 | ||
Ongoing Assessment | 598 | ||
Therapeutic Interventions | 598 | ||
Risk for Ineffective Breathing Pattern | 599 | ||
Common Risk Factor | 599 | ||
Common Expected Outcome | 599 | ||
Ongoing Assessment | 599 | ||
9 Musculoskeletal Care Plans | 632 | ||
Amputation, Lower Extremity | 632 | ||
Anxiety, Preoperative | 632 | ||
Common Related Factors | 632 | ||
Defining Characteristics | 632 | ||
Common Expected Outcomes | 632 | ||
Ongoing Assessment | 633 | ||
Therapeutic Interventions | 633 | ||
Risk for Impaired Skin Integrity | 634 | ||
Common Risk Factors | 634 | ||
Common Expected Outcome | 634 | ||
Ongoing Assessment | 634 | ||
Therapeutic Interventions | 635 | ||
Impaired Physical Mobility | 636 | ||
Common Related Factors | 636 | ||
Defining Characteristics | 636 | ||
Common Expected Outcomes | 636 | ||
Ongoing Assessment | 636 | ||
Therapeutic Interventions | 637 | ||
Disturbed Body Image | 638 | ||
Common Related Factors | 638 | ||
Defining Characteristics | 638 | ||
Common Expected Outcome | 638 | ||
Ongoing Assessment | 638 | ||
Therapeutic Interventions | 639 | ||
Acute Pain and Chronic Pain | 640 | ||
Common Related Factors | 640 | ||
Defining Characteristics | 640 | ||
Common Expected Outcomes | 640 | ||
Ongoing Assessment | 641 | ||
Therapeutic Interventions | 641 | ||
Deficient Knowledge | 642 | ||
Common Related Factors | 642 | ||
Defining Characteristics | 642 | ||
Common Expected Outcomes | 642 | ||
Ongoing Assessment | 642 | ||
Therapeutic Interventions | 642 | ||
Arthritis, Rheumatoid | 643 | ||
Deficient Knowledge | 643 | ||
Common Related Factors | 643 | ||
Defining Characteristics | 643 | ||
Common Expected Outcome | 644 | ||
Ongoing Assessment | 644 | ||
Therapeutic Interventions | 644 | ||
Chronic Joint Pain | 647 | ||
Common Related Factors | 647 | ||
Defining Characteristics | 647 | ||
Common Expected Outcomes | 647 | ||
Ongoing Assessment | 647 | ||
Therapeutic Interventions | 647 | ||
Joint Stiffness | 648 | ||
Common Related Factors | 648 | ||
Defining Characteristics | 648 | ||
Common Expected Outcomes | 648 | ||
Ongoing Assessment | 648 | ||
Therapeutic Interventions | 649 | ||
Impaired Physical Mobility | 649 | ||
Common Related Factors | 649 | ||
Defining Characteristics | 649 | ||
Common Expected Outcomes | 649 | ||
Ongoing Assessment | 650 | ||
Therapeutic Interventions | 650 | ||
Arthroscopy | 651.e1 | ||
Deficient Knowledge | 651.e1 | ||
Common Related Factors | 651.e1 | ||
Defining Characteristics | 651.e1 | ||
Common Expected Outcome | 651.e1 | ||
Ongoing Assessment | 651.e1 | ||
Therapeutic Interventions | 651.e2 | ||
Acute Pain | 651.e2 | ||
Common Related Factors | 651.e2 | ||
Defining Characteristics | 651.e2 | ||
Common Expected Outcomes | 651.e3 | ||
Ongoing Assessment | 651.e3 | ||
Therapeutic Interventions | 651.e3 | ||
Impaired Physical Mobility | 651.e3 | ||
Common Related Factors | 651.e3 | ||
Defining Characteristics | 651.e3 | ||
Common Expected Outcomes | 651.e4 | ||
Ongoing Assessment | 651.e4 | ||
Therapeutic Interventions | 651.e4 | ||
Fibromyalgia: Fibromyalgia Syndrome; Fibromyositis; Fibrositis | 651.e5 | ||
Deficient Knowledge | 651.e5 | ||
Common Related Factors | 651.e5 | ||
Defining Characteristics | 651.e5 | ||
Common Expected Outcome | 651.e5 | ||
Ongoing Assessment | 651.e5 | ||
Therapeutic Interventions | 651.e6 | ||
Chronic Pain | 651.e7 | ||
Common Related Factors | 651.e7 | ||
Defining Characteristics | 651.e7 | ||
Common Expected Outcomes | 651.e8 | ||
Ongoing Assessment | 651.e8 | ||
Therapeutic Interventions | 651.e8 | ||
Fatigue | 651.e9 | ||
Common Related Factors | 651.e9 | ||
Defining Characteristics | 651.e9 | ||
Common Expected Outcomes | 651.e9 | ||
Ongoing Assessment | 651.e10 | ||
Therapeutic Interventions | 651.e10 | ||
Fractures: Extremity and Pelvic: Closed Reduction; Open Reduction; Internal Fixation; External Fixation | 651 | ||
Acute Pain | 651 | ||
Common Related Factor | 651 | ||
Defining Characteristics | 651 | ||
Common Expected Outcomes | 651 | ||
Ongoing Assessment | 652 | ||
Therapeutic Interventions | 652 | ||
Impaired Physical Mobility | 653 | ||
Common Related Factors | 653 | ||
Defining Characteristics | 653 | ||
Common Expected Outcomes | 653 | ||
Ongoing Assessment | 653 | ||
Therapeutic Interventions | 654 | ||
Risk for Ineffective Peripheral Tissue Perfusion | 654 | ||
Common Risk Factors | 654 | ||
Common Expected Outcome | 654 | ||
Ongoing Assessment | 655 | ||
Therapeutic Interventions | 656 | ||
Deficient Knowledge | 656 | ||
Common Related Factors | 656 | ||
Defining Characteristics | 656 | ||
Common Expected Outcome | 656 | ||
Ongoing Assessment | 657 | ||
Therapeutic Interventions | 657 | ||
Risk for Impaired Urinary Elimination | 658 | ||
Common Risk Factors | 658 | ||
Common Expected Outcome | 658 | ||
Ongoing Assessment | 658 | ||
Therapeutic Interventions | 659 | ||
Risk for Injury | 659 | ||
Common Risk Factors | 659 | ||
Common Expected Outcomes | 659 | ||
Ongoing Assessment | 659 | ||
Therapeutic Interventions | 660 | ||
Joint Arthroplasty/Replacement: Total Hip, Knee, Shoulder | 660 | ||
Acute Pain | 661 | ||
Common Related Factor | 661 | ||
Defining Characteristics | 661 | ||
Common Expected Outcomes | 661 | ||
Ongoing Assessment | 662 | ||
Therapeutic Interventions | 662 | ||
Impaired Physical Mobility | 663 | ||
Common Related Factors | 663 | ||
Defining Characteristics | 663 | ||
Common Expected Outcomes | 663 | ||
Ongoing Assessment | 663 | ||
Therapeutic Interventions | 663 | ||
Risk for Ineffective Peripheral Tissue Perfusion | 664 | ||
Common Risk Factors | 664 | ||
Common Expected Outcomes | 665 | ||
Ongoing Assessment | 665 | ||
Therapeutic Interventions | 666 | ||
Deficient Knowledge | 666 | ||
Common Related Factors | 666 | ||
Defining Characteristics | 666 | ||
Common Expected Outcome | 667 | ||
Ongoing Assessment | 667 | ||
Therapeutic Interventions | 667 | ||
Osteoarthritis | 668 | ||
Acute Pain/Chronic Pain | 669 | ||
Common Related Factors | 669 | ||
Defining Characteristics | 669 | ||
Common Expected Outcomes | 669 | ||
Ongoing Assessment | 669 | ||
Therapeutic Interventions | 670 | ||
Impaired Physical Mobility | 671 | ||
Common Related Factors | 671 | ||
Defining Characteristics | 671 | ||
Common Expected Outcomes | 671 | ||
Ongoing Assessment | 671 | ||
Therapeutic Interventions | 672 | ||
Osteomyelitis: Bone Infection | 673.e1 | ||
Infection | 673.e1 | ||
Common Related Factors | 673.e1 | ||
Defining Characteristics | 673.e1 | ||
Common Expected Outcome | 673.e1 | ||
Ongoing Assessment | 673.e1 | ||
Therapeutic Interventions | 673.e2 | ||
Acute Pain | 673.e2 | ||
Common Related Factor | 673.e2 | ||
Defining Characteristics | 673.e2 | ||
Common Expected Outcomes | 673.e3 | ||
Ongoing Assessment | 673.e3 | ||
Therapeutic Interventions | 673.e3 | ||
Osteoporosis: Brittle Bone | 673 | ||
Deficient Knowledge | 673 | ||
Common Related Factors | 673 | ||
Defining Characteristics | 673 | ||
Common Expected Outcomes | 674 | ||
Ongoing Assessment | 674 | ||
Therapeutic Interventions | 675 | ||
Risk for Falls | 677 | ||
Common Risk Factors | 677 | ||
Common Expected Outcomes | 677 | ||
Ongoing Assessment | 677 | ||
Therapeutic Interventions | 678 | ||
Disturbed Body Image | 678 | ||
Common Related Factors | 678 | ||
Defining Characteristics | 678 | ||
Common Expected Outcome | 678 | ||
Ongoing Assessment | 678 | ||
Therapeutic Interventions | 679 | ||
Traction: Skeletal Traction; Skin Traction | 679.e1 | ||
Deficient Knowledge | 679.e1 | ||
Common Related Factors | 679.e1 | ||
Defining Characteristics | 679.e1 | ||
Common Expected Outcome | 679.e1 | ||
Ongoing Assessment | 679.e1 | ||
Therapeutic Interventions | 679.e2 | ||
Acute Pain | 679.e3 | ||
Common Related Factor | 679.e3 | ||
Defining Characteristics | 679.e3 | ||
Common Expected Outcomes | 679.e3 | ||
Ongoing Assessment | 679.e3 | ||
Therapeutic Interventions | 679.e3 | ||
Impaired Physical Mobility | 679.e4 | ||
Common Related Factors | 679.e4 | ||
Defining Characteristics | 679.e4 | ||
Common Expected Outcomes | 679.e4 | ||
Ongoing Assessment | 679.e5 | ||
Therapeutic Interventions | 679.e5 | ||
Risk for Ineffective Peripheral Tissue Perfusion | 679.e5 | ||
Common Risk Factor | 679.e5 | ||
Common Expected Outcome | 679.e5 | ||
Ongoing Assessment | 679.e6 | ||
Therapeutic Interventions | 679.e6 | ||
Risk for Infection: Pin Sites | 679.e6 | ||
Common Risk Factors | 679.e6 | ||
Common Expected Outcomes | 679.e7 | ||
Ongoing Assessment | 679.e7 | ||
Therapeutic Interventions | 679.e7 | ||
10 Hematolymphatic, Immunological, and Oncological Care Plans | 680 | ||
Anemia: Iron Deficiency; Cobalamin (Vitamin B12) Deficiency; Pernicious Anemia; Aplastic Anemia | 680 | ||
Deficient Knowledge | 681 | ||
Common Related Factors | 681 | ||
Defining Characteristics | 681 | ||
Common Expected Outcome | 681 | ||
Ongoing Assessment | 681 | ||
Therapeutic Interventions | 681 | ||
Fatigue | 683 | ||
Common Related Factor | 683 | ||
Defining Characteristics | 683 | ||
Common Expected Outcomes | 683 | ||
Ongoing Assessment | 683 | ||
Therapeutic Interventions | 684 | ||
Risk for Bleeding | 684 | ||
Common Risk Factors | 684 | ||
Common Expected Outcome | 684 | ||
Ongoing Assessment | 684 | ||
Therapeutic Interventions | 685 | ||
Risk for Infection | 685 | ||
Common Risk Factors | 685 | ||
Common Expected Outcome | 685 | ||
Ongoing Assessment | 685 | ||
Therapeutic Interventions | 686 | ||
Cancer Chemotherapy | 686 | ||
Deficient Knowledge | 687 | ||
Common Related Factors | 687 | ||
Defining Characteristics | 687 | ||
Common Expected Outcome | 687 | ||
Ongoing Assessment | 687 | ||
Therapeutic Interventions | 687 | ||
Nausea | 689 | ||
Common Related Factors | 689 | ||
Defining Characteristics | 689 | ||
Common Expected Outcome | 689 | ||
Ongoing Assessment | 689 | ||
Therapeutic Interventions | 690 | ||
Cancer-Related Fatigue | 691 | ||
Common Related Factors | 691 | ||
Defining Characteristics | 691 | ||
Common Expected Outcomes | 692 | ||
Ongoing Assessment | 692 | ||
Therapeutic Interventions | 692 | ||
Risk for Infection | 693 | ||
Common Risk Factors | 693 | ||
Common Expected Outcome | 693 | ||
Ongoing Assessment | 693 | ||
Therapeutic Interventions | 693 | ||
Risk for Bleeding | 694 | ||
Common Risk Factors | 694 | ||
Common Expected Outcome | 694 | ||
Ongoing Assessment | 695 | ||
Therapeutic Interventions | 695 | ||
Risk for Injury | 696 | ||
Common Risk Factors | 696 | ||
Common Expected Outcome | 696 | ||
Ongoing Assessment | 696 | ||
Therapeutic Interventions | 697 | ||
Disturbed Body Image | 698 | ||
Common Related Factors | 698 | ||
Defining Characteristics | 698 | ||
Common Expected Outcomes | 698 | ||
Ongoing Assessment | 698 | ||
Therapeutic Interventions | 698 | ||
Risk for Injury | 699 | ||
Common Risk Factor | 699 | ||
Common Expected Outcome | 699 | ||
Ongoing Assessment | 699 | ||
Therapeutic Interventions | 699 | ||
Cancer Radiation Therapy: External Beam; Brachytherapy; Teletherapy; Radiotherapy | 700 | ||
Deficient Knowledge | 700 | ||
Common Related Factors | 700 | ||
Defining Characteristics | 700 | ||
Common Expected Outcome | 701 | ||
Ongoing Assessment | 701 | ||
Therapeutic Interventions | 701 | ||
Risk for Impaired Skin Integrity | 702 | ||
Common Risk Factor | 702 | ||
Common Expected Outcome | 702 | ||
Ongoing Assessment | 702 | ||
Therapeutic Interventions | 703 | ||
Risk for Injury (Radiation Exposure) | 703 | ||
Common Risk Factors | 703 | ||
Common Expected Outcome | 704 | ||
Ongoing Assessment | 704 | ||
Therapeutic Interventions | 704 | ||
Disseminated Intravascular Coagulation: Coagulopathy; Defibrination Syndrome; DIC | 705 | ||
Risk for Bleeding | 705 | ||
Common Risk Factors | 705 | ||
Common Expected Outcomes | 705 | ||
Ongoing Assessment | 706 | ||
Therapeutic Interventions | 707 | ||
Impaired Gas Exchange | 708 | ||
Common Related Factor | 708 | ||
Defining Characteristics | 708 | ||
Common Expected Outcome | 708 | ||
Ongoing Assessment | 708 | ||
Therapeutic Interventions | 708 | ||
Deficient Knowledge | 709 | ||
Common Related Factors | 709 | ||
Defining Characteristics | 709 | ||
Common Expected Outcome | 709 | ||
Ongoing Assessment | 709 | ||
Therapeutic Interventions | 709 | ||
Hematopoietic Stem Cell Collection: Bone Marrow Donor; Bone Marrow Transplantation; Apheresis; Peripheral Blood Stem Cell Donor; Autologous; Allogenic; Syngeneic | 710.e1 | ||
Deficient Knowledge | 710.e1 | ||
Common Related Factors | 710.e1 | ||
Defining Characteristics | 710.e1 | ||
Common Expected Outcome | 710.e1 | ||
Ongoing Assessment | 710.e1 | ||
Therapeutic Interventions | 710.e2 | ||
Fear | 710.e4 | ||
Common Related Factors | 710.e4 | ||
Defining Characteristics | 710.e4 | ||
Common Expected Outcomes | 710.e4 | ||
Ongoing Assessment | 710.e4 | ||
Therapeutic Interventions | 710.e4 | ||
Risk for Infection | 710.e5 | ||
Common Risk Factor | 710.e5 | ||
Common Expected Outcome | 710.e5 | ||
Ongoing Assessment | 710.e5 | ||
Therapeutic Interventions | 710.e5 | ||
Hematopoietic Stem Cell Transplantation: Bone Marrow Transplant; Peripheral Blood Stem Cell Transplant | 710 | ||
Deficient Knowledge | 711 | ||
Common Related Factors | 711 | ||
Defining Characteristics | 711 | ||
Common Expected Outcome | 711 | ||
Ongoing Assessment | 711 | ||
Therapeutic Interventions | 711 | ||
Risk for Infection | 714 | ||
Common Risk Factors | 714 | ||
Common Expected Outcome | 714 | ||
Ongoing Assessment | 714 | ||
Therapeutic Interventions | 715 | ||
Ineffective Protection | 716 | ||
Common Related Factors | 716 | ||
Defining Characteristics | 716 | ||
Common Expected Outcomes | 716 | ||
Ongoing Assessment | 716 | ||
Therapeutic Interventions | 718 | ||
Diarrhea | 720 | ||
Common Related Factors | 720 | ||
Defining Characteristics | 720 | ||
Common Expected Outcomes | 720 | ||
Ongoing Assessment | 720 | ||
Therapeutic Interventions | 721 | ||
Risk for Imbalanced Nutrition: Less Than Body Requirements | 721 | ||
Common Risk Factors | 721 | ||
Common Expected Outcome | 721 | ||
Ongoing Assessment | 721 | ||
Therapeutic Interventions | 722 | ||
Hemophilia: Clotting Abnormality; Factor VIII Deficiency; Factor IX Deficiency; Hemophilia A; Hemophilia B | 723.e1 | ||
Risk for Bleeding | 723.e1 | ||
Common Risk Factor | 723.e1 | ||
Common Expected Outcomes | 723.e1 | ||
Ongoing Assessment | 723.e1 | ||
Therapeutic Interventions | 723.e2 | ||
Acute Pain | 723.e3 | ||
Common Related Factors | 723.e3 | ||
Defining Characteristics | 723.e3 | ||
Common Expected Outcomes | 723.e3 | ||
Ongoing Assessment | 723.e3 | ||
Therapeutic Interventions | 723.e3 | ||
Risk for Impaired Physical Mobility | 723.e4 | ||
Common Risk Factors | 723.e4 | ||
Common Expected Outcome | 723.e4 | ||
Ongoing Assessment | 723.e4 | ||
Therapeutic Interventions | 723.e4 | ||
Deficient Knowledge | 723.e4 | ||
Common Related Factors | 723.e4 | ||
Defining Characteristics | 723.e4 | ||
Common Expected Outcome | 723.e5 | ||
Ongoing Assessment | 723.e5 | ||
Therapeutic Interventions | 723.e5 | ||
Human Immunodeficiency Virus (HIV) Disease: Acquired Immunodeficiency Syndrome (AIDS) | 723 | ||
Deficient Knowledge: Disease and Transmission | 723 | ||
Common Related Factors | 723 | ||
Defining Characteristics | 723 | ||
Common Expected Outcome | 724 | ||
Ongoing Assessment | 724 | ||
Therapeutic Interventions | 724 | ||
Infection | 726 | ||
Common Related Factor | 726 | ||
Defining Characteristics | 726 | ||
Common Expected Outcomes | 726 | ||
Ongoing Assessment | 726 | ||
Therapeutic Interventions | 726 | ||
Imbalanced Nutrition: Less Than Body Requirements | 727 | ||
Common Related Factors | 727 | ||
Defining Characteristics | 727 | ||
Common Expected Outcomes | 728 | ||
Ongoing Assessment | 728 | ||
Therapeutic Interventions | 728 | ||
Leukemia, Adult: Acute Lymphocytic Leukemia; Acute Myelocytic Leukemia; Chronic Lymphocytic Leukemia; Lymphocytic Leukemia; Chronic Myelocytic Leukemia; Nonlymphocytic Leukemia; Myelogenous Leukemia; Granulocytic Leukemia | 729 | ||
Deficient Knowledge | 729 | ||
Common Related Factors | 729 | ||
Defining Characteristics | 729 | ||
Common Expected Outcome | 729 | ||
Ongoing Assessment | 730 | ||
Therapeutic Interventions | 730 | ||
Risk for Ineffective Coping | 731 | ||
Common Risk Factors | 731 | ||
Common Expected Outcomes | 731 | ||
Ongoing Assessment | 731 | ||
Therapeutic Interventions | 732 | ||
Risk for Infection | 733 | ||
Common Risk Factors | 733 | ||
Common Expected Outcome | 733 | ||
Ongoing Assessment | 733 | ||
Therapeutic Interventions | 733 | ||
Risk for Bleeding | 735 | ||
Common Risk Factors | 735 | ||
Common Expected Outcome | 735 | ||
Ongoing Assessment | 735 | ||
Therapeutic Interventions | 735 | ||
Cancer-Related Fatigue | 736 | ||
Common Related Factors | 736 | ||
Defining Characteristics | 736 | ||
Common Expected Outcomes | 737 | ||
Ongoing Assessment | 737 | ||
Therapeutic Interventions | 737 | ||
Nausea | 738 | ||
Common Related Factors | 738 | ||
Defining Characteristics | 738 | ||
Common Expected Outcome | 738 | ||
Ongoing Assessment | 738 | ||
Therapeutic Interventions | 739 | ||
Lymphoma: Hodgkin’s Lymphoma; Non-Hodgkin’s Lymphoma | 740 | ||
Deficient Knowledge | 741 | ||
Common Related Factors | 741 | ||
Defining Characteristics | 741 | ||
Common Expected Outcome | 741 | ||
Ongoing Assessment | 741 | ||
Therapeutic Interventions | 741 | ||
Cancer-Related Fatigue | 743 | ||
Common Related Factors | 743 | ||
Defining Characteristics | 743 | ||
Common Expected Outcomes | 743 | ||
Ongoing Assessment | 743 | ||
Therapeutic Interventions | 743 | ||
Risk for Ineffective Coping | 744 | ||
Common Risk Factors | 744 | ||
Common Expected Outcome | 744 | ||
Ongoing Assessment | 744 | ||
Therapeutic Interventions | 745 | ||
Risk for Infection | 745 | ||
Common Risk Factors | 745 | ||
Common Expected Outcome | 745 | ||
Ongoing Assessment | 746 | ||
Therapeutic Interventions | 746 | ||
Risk for Bleeding | 747 | ||
Common Risk Factor | 747 | ||
Common Expected Outcome | 747 | ||
Ongoing Assessment | 747 | ||
Therapeutic Interventions | 748 | ||
Nausea | 749 | ||
Common Related Factors | 749 | ||
Defining Characteristics | 749 | ||
Common Expected Outcome | 749 | ||
Ongoing Assessment | 749 | ||
Therapeutic Interventions | 750 | ||
Multiple Myeloma: Plasma Cell Myeloma; Monoclonal Gammopathy of Undetermined Significance (MGUS) | 752 | ||
Deficient Knowledge | 752 | ||
Common Related Factors | 752 | ||
Defining Characteristics | 752 | ||
Common Expected Outcome | 752 | ||
Ongoing Assessment | 752 | ||
Therapeutic Interventions | 753 | ||
Acute Pain | 753 | ||
Common Related Factors | 753 | ||
Defining Characteristics | 753 | ||
Common Expected Outcomes | 754 | ||
Ongoing Assessment | 754 | ||
Therapeutic Interventions | 754 | ||
Impaired Physical Mobility | 755 | ||
Common Related Factors | 755 | ||
Defining Characteristics | 755 | ||
Common Expected Outcomes | 755 | ||
Ongoing Assessment | 755 | ||
Therapeutic Interventions | 755 | ||
Risk for Impaired Urinary Elimination | 756 | ||
Common Risk Factors | 756 | ||
Common Expected Outcome | 756 | ||
Ongoing Assessment | 756 | ||
Therapeutic Interventions | 756 | ||
Ineffective Protection | 757 | ||
Common Related Factors | 757 | ||
Defining Characteristics | 757 | ||
Common Expected Outcomes | 757 | ||
Ongoing Assessment | 757 | ||
Therapeutic Interventions | 758 | ||
Neutropenia: Granulocytopenia | 759 | ||
Risk for Infection | 759 | ||
Common Risk Factors | 759 | ||
Common Expected Outcome | 759 | ||
Ongoing Assessment | 760 | ||
Therapeutic Interventions | 760 | ||
Deficient Knowledge | 762 | ||
Common Related Factors | 762 | ||
Defining Characteristics | 762 | ||
Common Expected Outcome | 762 | ||
Ongoing Assessment | 762 | ||
Therapeutic Interventions | 762 | ||
Organ Transplantation, Solid: Heart Transplantation; Lung Transplantation; Liver Transplantation; Kidney Transplantation; Living Kidney Donors | 764.e1 | ||
Heart Transplantation | 764.e1 | ||
Decreased Cardiac Output | 764.e1 | ||
Common Related Factors | 764.e1 | ||
Defining Characteristics | 764.e1 | ||
Common Expected Outcome | 764.e1 | ||
Ongoing Assessment | 764.e2 | ||
Therapeutic Interventions | 764.e2 | ||
Risk for Decreased Cardiac Output: Right Ventricular Failure | 764.e3 | ||
Common Risk Factors | 764.e3 | ||
Common Expected Outcome | 764.e3 | ||
Ongoing Assessment | 764.e3 | ||
Therapeutic Interventions | 764.e4 | ||
Risk for Bleeding/Hemorrhage | 764.e4 | ||
Common Risk Factors | 764.e4 | ||
Common Expected Outcome | 764.e4 | ||
Ongoing Assessment | 764.e5 | ||
Therapeutic Interventions | 764.e5 | ||
Ineffective Protection (After Heart Transplantation) | 764.e6 | ||
Common Related Factor | 764.e6 | ||
Defining Characteristics | 764.e6 | ||
Common Expected Outcomes | 764.e6 | ||
Ongoing Assessment | 764.e6 | ||
Therapeutic Interventions | 764.e6 | ||
Lung Transplantation | 764.e7 | ||
Ineffective Airway Clearance | 764.e7 | ||
Common Related Factors | 764.e7 | ||
Defining Characteristics | 764.e7 | ||
Common Expected Outcome | 764.e7 | ||
Ongoing Assessment | 764.e7 | ||
Therapeutic Interventions | 764.e8 | ||
Ineffective Protection (After Lung Transplantation) | 764.e9 | ||
Common Related Factors | 764.e9 | ||
Defining Characteristics | 764.e9 | ||
Common Expected Outcomes | 764.e9 | ||
Ongoing Assessment | 764.e9 | ||
Therapeutic Interventions | 764.e10 | ||
Liver Transplantation | 764.e10 | ||
Risk for Bleeding/Hemorrhage | 764.e10 | ||
Common Risk Factors | 764.e10 | ||
Common Expected Outcome | 764.e10 | ||
Ongoing Assessment | 764.e11 | ||
Therapeutic Interventions | 764.e11 | ||
Ineffective Protection (After Liver Transplantation) | 764.e11 | ||
Common Related Factors | 764.e11 | ||
Defining Characteristics | 764.e11 | ||
Common Expected Outcomes | 764.e11 | ||
Ongoing Assessment | 764.e12 | ||
Therapeutic Interventions | 764.e12 | ||
Kidney Transplantation | 764.e12 | ||
Kidney Transplant Recipient | 764.e12 | ||
Risk for Ineffective Renal Perfusion | 764.e12 | ||
Common Risk Factors | 764.e12 | ||
Common Expected Outcome | 764.e13 | ||
Ongoing Assessment | 764.e13 | ||
Therapeutic Interventions | 764.e13 | ||
Ineffective Protection (Transplanted Kidney) | 764.e14 | ||
Common Related Factors | 764.e14 | ||
Defining Characteristics | 764.e14 | ||
Common Expected Outcomes | 764.e14 | ||
Ongoing Assessment | 764.e14 | ||
Therapeutic Interventions | 764.e15 | ||
Living Kidney Donors | 764.e15 | ||
Deficient Knowledge | 764.e15 | ||
Common Related Factors | 764.e15 | ||
Defining Characteristics | 764.e15 | ||
Common Expected Outcome | 764.e16 | ||
Ongoing Assessment | 764.e16 | ||
Therapeutic Interventions | 764.e16 | ||
Problems Common to Solid Organ Transplant Recipients: Risk for Infection, Ineffective Coping, and Knowledge Deficit | 764.e17 | ||
Risk for Infection | 764.e17 | ||
Common Risk Factors | 764.e17 | ||
Common Expected Outcomes | 764.e17 | ||
Ongoing Assessment | 764.e17 | ||
Therapeutic Interventions | 764.e18 | ||
Risk for Ineffective Coping | 764.e18 | ||
Common Risk Factors | 764.e18 | ||
Common Expected Outcomes | 764.e19 | ||
Ongoing Assessment | 764.e19 | ||
Therapeutic Interventions | 764.e19 | ||
Deficient Knowledge | 764.e20 | ||
Common Related Factors | 764.e20 | ||
Defining Characteristics | 764.e20 | ||
Common Expected Outcome | 764.e20 | ||
Ongoing Assessment | 764.e20 | ||
Therapeutic Interventions | 764.e20 | ||
Sickle Cell Disease: Vasoocclusive Event; Sickle Cell Pain Crisis; Sickle Cell Anemia | 764.e21 | ||
Risk for Ineffective Health Management | 764.e22 | ||
Common Risk Factors | 764.e22 | ||
Common Expected Outcomes | 764.e22 | ||
Ongoing Assessment | 764.e22 | ||
Therapeutic Interventions | 764.e22 | ||
Acute Pain | 764.e23 | ||
Common Related Factor | 764.e23 | ||
Defining Characteristics | 764.e23 | ||
Common Expected Outcomes | 764.e23 | ||
Ongoing Assessment | 764.e24 | ||
Therapeutic Interventions | 764.e24 | ||
Risk for Ineffective Coping | 764.e25 | ||
Common Risk Factors | 764.e25 | ||
Common Expected Outcomes | 764.e25 | ||
Ongoing Assessment | 764.e25 | ||
Therapeutic Interventions | 764.e26 | ||
Systemic Lupus Erythematosus: SLE; Lupus | 764 | ||
Deficient Knowledge | 765 | ||
Common Related Factors | 765 | ||
Defining Characteristics | 765 | ||
Common Expected Outcome | 765 | ||
Ongoing Assessment | 765 | ||
Therapeutic Interventions | 765 | ||
Impaired Skin Integrity | 767 | ||
Common Related Factors | 767 | ||
Defining Characteristics | 767 | ||
Common Expected Outcomes | 767 | ||
Ongoing Assessment | 767 | ||
Therapeutic Interventions | 768 | ||
Joint Pain/Stiffness | 769 | ||
Common Related Factor | 769 | ||
Defining Characteristics | 769 | ||
Common Expected Outcomes | 769 | ||
Ongoing Assessment | 769 | ||
Therapeutic Interventions | 769 | ||
Fatigue | 770 | ||
Common Related Factors | 770 | ||
Defining Characteristics | 770 | ||
Common Expected Outcomes | 770 | ||
Ongoing Assessment | 771 | ||
Therapeutic Interventions | 771 | ||
11 Renal and Urinary Tract Care Plans | 772 | ||
Acute Kidney Injury: Acute Tubular Necrosis (ATN); Renal Insufficiency; Acute Renal Failure | 772 | ||
Impaired Renal Function | 772 | ||
Common Related Factors | 772 | ||
Defining Characteristics | 772 | ||
Common Expected Outcome | 772 | ||
Ongoing Assessment | 773 | ||
Therapeutic Interventions | 774 | ||
Excess Fluid Volume | 775 | ||
Common Related Factors | 775 | ||
Defining Characteristics | 775 | ||
Common Expected Outcome | 775 | ||
Ongoing Assessment | 775 | ||
Therapeutic Interventions | 775 | ||
Risk for Decreased Cardiac Output | 776 | ||
Common Risk Factors | 776 | ||
Common Expected Outcome | 776 | ||
Ongoing Assessment | 776 | ||
Therapeutic Interventions | 777 | ||
Imbalanced Nutrition: Less Than Body Requirements | 778 | ||
Common Related Factors | 778 | ||
Defining Characteristics | 778 | ||
Common Expected Outcomes | 778 | ||
Ongoing Assessment | 778 | ||
Therapeutic Interventions | 779 | ||
Risk for Infection | 779 | ||
Common Risk Factors | 779 | ||
Common Expected Outcomes | 779 | ||
Ongoing Assessment | 780 | ||
Therapeutic Interventions | 780 | ||
Deficient Knowledge | 780 | ||
Common Related Factors | 780 | ||
Defining Characteristics | 780 | ||
Common Expected Outcome | 780 | ||
Ongoing Assessment | 781 | ||
Therapeutic Interventions | 781 | ||
Chronic Kidney Disease (CKD): Uremia; Renal Failure; Chronic/End-Stage Renal Disease | 781 | ||
Deficient Knowledge | 782 | ||
Common Related Factors | 782 | ||
Defining Characteristics | 782 | ||
Common Expected Outcome | 782 | ||
Ongoing Assessment | 782 | ||
Therapeutic Interventions | 783 | ||
Excess Fluid Volume | 784 | ||
Common Related Factors | 784 | ||
Defining Characteristics | 784 | ||
Common Expected Outcome | 784 | ||
Ongoing Assessment | 784 | ||
Therapeutic Interventions | 784 | ||
Risk for Decreased Cardiac Output | 785 | ||
Common Risk Factors | 785 | ||
Common Expected Outcome | 785 | ||
Ongoing Assessment | 785 | ||
Therapeutic Interventions | 786 | ||
Risk for Electrolyte Imbalance: CKD Mineral and Bone Disorders | 787 | ||
Common Risk Factors | 787 | ||
Common Expected Outcomes | 787 | ||
Ongoing Assessment | 787 | ||
Therapeutic Interventions | 788 | ||
Ineffective Protection: Anemia/Thrombocytopenia | 788 | ||
Common Related Factors | 788 | ||
Defining Characteristics | 788 | ||
Common Expected Outcome | 789 | ||
Ongoing Assessment | 789 | ||
Therapeutic Interventions | 789 | ||
Risk for Situational Low Self-Esteem | 790 | ||
Common Risk Factors | 790 | ||
Common Expected Outcome | 790 | ||
Ongoing Assessment | 790 | ||
Therapeutic Interventions | 791 | ||
Sexual Dysfunction | 791 | ||
Common Related Factor | 791 | ||
Defining Characteristics | 791 | ||
Common Expected Outcome | 791 | ||
Ongoing Assessment | 792 | ||
Therapeutic Interventions | 792 | ||
Glomerulonephritis: Acute Poststreptococcal Glomerulonephritis; Acute Glomerulonephritis; Rapidly Progressive Glomerulonephritis; Chronic Glomerulonephritis | 792.e1 | ||
Excess Fluid Volume | 792.e1 | ||
Common Related Factor | 792.e1 | ||
Defining Characteristics | 792.e1 | ||
Common Expected Outcome | 792.e1 | ||
Ongoing Assessment | 792.e1 | ||
Therapeutic Interventions | 792.e2 | ||
Deficient Knowledge | 792.e2 | ||
Common Related Factors | 792.e2 | ||
Defining Characteristics | 792.e2 | ||
Common Expected Outcome | 792.e3 | ||
Ongoing Assessment | 792.e3 | ||
Therapeutic Interventions | 792.e3 | ||
Hemodialysis: Internal Arteriovenous Fistula; Graft; Central Venous Catheter; Renal Replacement Therapy | 792 | ||
Risk for Decreased Cardiac Output | 793 | ||
Common Risk Factors | 793 | ||
Common Expected Outcome | 793 | ||
Ongoing Assessment | 793 | ||
Therapeutic Interventions | 794 | ||
Risk for Infection | 794 | ||
Common Risk Factors | 794 | ||
Common Expected Outcomes | 794 | ||
Ongoing Assessment | 794 | ||
Therapeutic Interventions | 795 | ||
Risk for Ineffective Peripheral Tissue Perfusion | 796 | ||
Common Risk Factor | 796 | ||
Common Expected Outcome | 796 | ||
Ongoing Assessment | 796 | ||
Therapeutic Interventions | 796 | ||
Deficient Knowledge | 797 | ||
Common Related Factors | 797 | ||
Defining Characteristics | 797 | ||
Common Expected Outcome | 797 | ||
Ongoing Assessment | 797 | ||
Therapeutic Interventions | 797 | ||
Peritoneal Dialysis: Intermittent Peritoneal Dialysis; Continuous Ambulatory Peritoneal Dialysis; Continuous Cyclic Peritoneal Dialysis; Renal Replacement Therapy | 799 | ||
Excess Fluid Volume | 799 | ||
Common Related Factors | 799 | ||
Defining Characteristics | 799 | ||
Common Expected Outcome | 799 | ||
Ongoing Assessment | 799 | ||
Therapeutic Interventions | 800 | ||
Risk for Infection | 800 | ||
Common Risk Factors | 800 | ||
Common Expected Outcomes | 801 | ||
Ongoing Assessment | 801 | ||
Therapeutic Interventions | 801 | ||
Acute Pain | 802 | ||
Common Related Factors | 802 | ||
Defining Characteristics | 802 | ||
Common Expected Outcomes | 802 | ||
Ongoing Assessment | 802 | ||
Therapeutic Interventions | 803 | ||
Deficient Knowledge | 803 | ||
Common Related Factors | 803 | ||
Defining Characteristics | 803 | ||
Common Expected Outcomes | 803 | ||
Ongoing Assessment | 803 | ||
Therapeutic Interventions | 804 | ||
Renal Calculi: Kidney Stones; Urolithiasis; Nephrolithiasis; Staghorn Calculi | 805.e1 | ||
Deficient Knowledge | 805.e1 | ||
Common Related Factors | 805.e1 | ||
Defining Characteristics | 805.e1 | ||
Common Expected Outcome | 805.e1 | ||
Ongoing Assessment | 805.e1 | ||
Therapeutic Interventions | 805.e2 | ||
Acute Pain | 805.e4 | ||
Common Related Factors | 805.e4 | ||
Defining Characteristics | 805.e4 | ||
Common Expected Outcomes | 805.e4 | ||
Ongoing Assessment | 805.e4 | ||
Therapeutic Interventions | 805.e4 | ||
Risk for Infection | 805.e5 | ||
Common Risk Factors | 805.e5 | ||
Common Expected Outcome | 805.e5 | ||
Ongoing Assessment | 805.e5 | ||
Therapeutic Interventions | 805.e6 | ||
Urinary Diversion: Bladder Cancer; Ileal Conduit; Koch Pouch; Nephrostomy; Sigmoidostomy; Ureterostomy; Vesicostomy | 805 | ||
Deficient Knowledge: Preoperative | 805 | ||
Common Related Factors | 805 | ||
Defining Characteristics | 805 | ||
Common Expected Outcome | 806 | ||
Ongoing Assessment | 806 | ||
Therapeutic Interventions | 807 | ||
Risk for Toileting Self-Care Deficit | 807 | ||
Common Risk Factors | 807 | ||
Common Expected Outcome | 808 | ||
Ongoing Assessment | 808 | ||
Therapeutic Interventions | 808 | ||
Risk for Disturbed Body Image | 808 | ||
Common Risk Factors | 808 | ||
Common Expected Outcome | 809 | ||
Ongoing Assessment | 809 | ||
Therapeutic Interventions | 809 | ||
Risk for Ineffective Tissue Perfusion: Stoma | 810 | ||
Common Risk Factors | 810 | ||
Common Expected Outcome | 810 | ||
Ongoing Assessment | 810 | ||
Therapeutic Interventions | 810 | ||
Risk for Infection | 811 | ||
Common Risk Factors | 811 | ||
Common Expected Outcome | 811 | ||
Ongoing Assessment | 811 | ||
Therapeutic Interventions | 812 | ||
Deficient Knowledge: Stoma Care | 812 | ||
Common Related Factors | 812 | ||
Defining Characteristics | 812 | ||
Common Expected Outcome | 812 | ||
Ongoing Assessment | 812 | ||
Therapeutic Interventions | 814 | ||
Urinary Tract Infection: UTI; Pyelonephritis; Cystitis; Urethritis; Nephritis | 815 | ||
Infection | 815 | ||
Common Related Factors | 815 | ||
Defining Characteristics | 815 | ||
Common Expected Outcome | 815 | ||
Ongoing Assessment | 815 | ||
Therapeutic Interventions | 816 | ||
Acute Pain | 817 | ||
Common Related Factor | 817 | ||
Defining Characteristics | 817 | ||
Common Expected Outcomes | 817 | ||
Ongoing Assessment | 817 | ||
Therapeutic Interventions | 817 | ||
Deficient Knowledge | 818 | ||
Common Related Factors | 818 | ||
Defining Characteristics | 818 | ||
Common Expected Outcomes | 818 | ||
Ongoing Assessment | 818 | ||
Therapeutic Interventions | 818 | ||
12 Men’s and Women’s Health Care Plans | 820 | ||
General Health Care Plans | 820 | ||
Gender Dysphoria: Gender Identity; Transgender; Transsexual; Transman; Transwoman; Sex Reassignment Surgery | 820 | ||
Personal Identity Incongruence | 821 | ||
Common Related Factors | 821 | ||
Defining Characteristics | 821 | ||
Common Expected Outcomes | 821 | ||
Ongoing Assessment | 821 | ||
Therapeutic Interventions | 822 | ||
Deficient Knowledge | 823 | ||
Common Related Factors | 823 | ||
Defining Characteristics | 823 | ||
Common Expected Outcomes | 824 | ||
Ongoing Assessment | 824 | ||
Therapeutic Interventions | 824 | ||
Sexually Transmitted Diseases | 827 | ||
Deficient Knowledge | 827 | ||
Common Related Factors | 827 | ||
Defining Characteristics | 827 | ||
Common Expected Outcome | 827 | ||
Ongoing Assessment | 827 | ||
Therapeutic Interventions | 828 | ||
Infection | 829 | ||
Common Related Factors | 829 | ||
Defining Characteristics | 829 | ||
Common Expected Outcome | 829 | ||
Ongoing Assessment | 829 | ||
Therapeutic Interventions | 830 | ||
Disturbed Body Image | 832 | ||
Common Related Factors | 832 | ||
Defining Characteristics | 832 | ||
Common Expected Outcome | 832 | ||
Ongoing Assessment | 832 | ||
Therapeutic Interventions | 833 | ||
Men’s Health Care Plans | 833 | ||
Benign Prostatic Hyperplasia | 833 | ||
Urinary Retention | 834 | ||
Common Related Factor | 834 | ||
Defining Characteristics | 834 | ||
Common Expected Outcome | 834 | ||
Ongoing Assessment | 834 | ||
Therapeutic Interventions | 835 | ||
Deficient Knowledge | 836 | ||
Common Related Factors | 836 | ||
Defining Characteristics | 836 | ||
Common Expected Outcome | 836 | ||
Ongoing Assessment | 836 | ||
Therapeutic Interventions | 838 | ||
Risk for Deficient Fluid Volume | 839 | ||
Common Risk Factors | 839 | ||
Common Expected Outcome | 839 | ||
Ongoing Assessment | 839 | ||
Therapeutic Interventions | 839 | ||
Erectile Dysfunction: Impotence | 840.e1 | ||
Sexual Dysfunction | 840.e1 | ||
Common Related Factor | 840.e1 | ||
Defining Characteristics | 840.e1 | ||
Common Expected Outcomes | 840.e1 | ||
Ongoing Assessment | 840.e2 | ||
Therapeutic Interventions | 840.e2 | ||
Situational Low Self-Esteem/Disturbed Body Image | 840.e3 | ||
Common Related Factors | 840.e3 | ||
Defining Characteristics | 840.e3 | ||
Common Expected Outcomes | 840.e4 | ||
Ongoing Assessment | 840.e4 | ||
Therapeutic Interventions | 840.e4 | ||
Prostate Cancer: Radical Prostatectomy; Localized Prostate Cancer | 840 | ||
Fear | 840 | ||
Common Related Factors | 840 | ||
Defining Characteristics | 840 | ||
Common Expected Outcomes | 841 | ||
Ongoing Assessment | 841 | ||
Therapeutic Interventions | 841 | ||
Risk for Sexual Dysfunction | 842 | ||
Common Risk Factors | 842 | ||
Common Expected Outcomes | 842 | ||
Ongoing Assessment | 842 | ||
Therapeutic Interventions | 843 | ||
Deficient Knowledge: Postoperative | 843 | ||
Common Related Factors | 843 | ||
Defining Characteristics | 843 | ||
Common Expected Outcome | 843 | ||
Ongoing Assessment | 843 | ||
Therapeutic Interventions | 844 | ||
Testicular Cancer | 845 | ||
Health-Seeking Behaviors: Technique for Monthly Testicular Self-Examination | 845 | ||
Common Related Factor | 845 | ||
Defining Characteristics | 845 | ||
Common Expected Outcome | 845 | ||
Ongoing Assessment | 845 | ||
Therapeutic Interventions | 846 | ||
Deficient Knowledge | 846 | ||
Common Related Factors | 846 | ||
Defining Characteristics | 846 | ||
Common Expected Outcome | 846 | ||
Ongoing Assessment | 846 | ||
Therapeutic Interventions | 847 | ||
Ineffective Sexuality Pattern | 848 | ||
Common Related Factors | 848 | ||
Defining Characteristics | 848 | ||
Common Expected Outcome | 848 | ||
Ongoing Assessment | 848 | ||
Therapeutic Interventions | 849 | ||
Disturbed Body Image | 849 | ||
Common Related Factors | 849 | ||
Defining Characteristics | 849 | ||
Common Expected Outcome | 849 | ||
Ongoing Assessment | 849 | ||
Therapeutic Interventions | 850 | ||
Women’s Health Care Plans | 850 | ||
Breast Cancer/Surgical Management With Breast Reconstruction Option | 850 | ||
Deficient Knowledge: Preoperative | 851 | ||
Common Related Factors | 851 | ||
Defining Characteristics | 851 | ||
Common Expected Outcome | 851 | ||
Ongoing Assessment | 852 | ||
Therapeutic Interventions | 852 | ||
Acute Pain | 854 | ||
Common Related Factors | 854 | ||
Defining Characteristics | 854 | ||
Common Expected Outcomes | 854 | ||
Ongoing Assessment | 855 | ||
Therapeutic Interventions | 855 | ||
Risk for Situational Low Self-Esteem/Disturbed Body Image | 855 | ||
Common Risk Factors | 855 | ||
Common Expected Outcome | 856 | ||
Ongoing Assessment | 856 | ||
Therapeutic Interventions | 856 | ||
Anxiety | 857 | ||
Common Related Factors | 857 | ||
Defining Characteristics | 857 | ||
Common Expected Outcomes | 857 | ||
Ongoing Assessment | 857 | ||
Therapeutic Interventions | 857 | ||
Deficient Knowledge: Postoperative | 858 | ||
Common Related Factors | 858 | ||
Defining Characteristics | 858 | ||
Common Expected Outcome | 858 | ||
Ongoing Assessment | 858 | ||
Therapeutic Interventions | 858 | ||
Cervical Cancer | 860 | ||
Deficient Knowledge | 860 | ||
Common Related Factors | 860 | ||
Defining Characteristics | 860 | ||
Common Expected Outcome | 860 | ||
Ongoing Assessment | 860 | ||
Therapeutic Interventions | 861 | ||
Risk for Ineffective Coping | 862 | ||
Common Risk Factors | 862 | ||
Common Expected Outcomes | 863 | ||
Ongoing Assessment | 863 | ||
Therapeutic Interventions | 863 | ||
Hysterectomy: Salpingectomy; Oophorectomy; Total Abdominal Hysterectomy; Cervical Cancer | 864 | ||
Deficient Knowledge: Surgical Treatment | 864 | ||
Common Related Factors | 864 | ||
Defining Characteristics | 864 | ||
Common Expected Outcomes | 864 | ||
Ongoing Assessment | 865 | ||
Therapeutic Interventions | 865 | ||
Deficient Knowledge: Surgical Menopause | 866 | ||
Common Related Factors | 866 | ||
Defining Characteristics | 866 | ||
Common Expected Outcome | 866 | ||
Ongoing Assessment | 866 | ||
Therapeutic Interventions | 867 | ||
Acute Pain | 868 | ||
Common Related Factors | 868 | ||
Defining Characteristics | 868 | ||
Common Expected Outcomes | 868 | ||
Ongoing Assessment | 868 | ||
Therapeutic Interventions | 869 | ||
Disturbed Body Image | 869 | ||
Common Related Factors | 869 | ||
Defining Characteristics | 869 | ||
Common Expected Outcomes | 869 | ||
Ongoing Assessment | 870 | ||
Therapeutic Interventions | 870 | ||
Menopause: Perimenopause; Hormone Therapy | 871 | ||
Deficient Knowledge | 872 | ||
Common Related Factors | 872 | ||
Defining Characteristics | 872 | ||
Common Expected Outcome | 872 | ||
Ongoing Assessment | 872 | ||
Therapeutic Interventions | 872 | ||
Ineffective Coping | 874 | ||
Common Related Factors | 874 | ||
Defining Characteristics | 874 | ||
Common Expected Outcomes | 874 | ||
Ongoing Assessment | 875 | ||
Therapeutic Interventions | 875 | ||
Ineffective Sexuality Pattern | 875 | ||
Common Related Factors | 875 | ||
Defining Characteristics | 875 | ||
Common Expected Outcomes | 875 | ||
Ongoing Assessment | 876 | ||
Therapeutic Interventions | 876 | ||
Insomnia | 876 | ||
Common Related Factor | 876 | ||
Defining Characteristics | 876 | ||
Common Expected Outcome | 877 | ||
Ongoing Assessment | 877 | ||
Therapeutic Interventions | 877 | ||
Ovarian Cancer | 878 | ||
Deficient Knowledge | 878 | ||
Common Related Factors | 878 | ||
Defining Characteristics | 878 | ||
Common Expected Outcomes | 878 | ||
Ongoing Assessment | 878 | ||
Therapeutic Interventions | 879 | ||
Acute Pain | 880 | ||
Common Related Factors | 880 | ||
Defining Characteristics | 880 | ||
Common Expected Outcomes | 880 | ||
Ongoing Assessment | 880 | ||
Therapeutic Interventions | 880 | ||
Risk for Ineffective Breathing Pattern | 881 | ||
Common Risk Factors | 881 | ||
Common Expected Outcome | 881 | ||
Ongoing Assessment | 881 | ||
Therapeutic Interventions | 882 | ||
Risk for Imbalanced Nutrition: Less Than Body Requirements | 882 | ||
Common Risk Factors | 882 | ||
Common Expected Outcome | 882 | ||
Ongoing Assessment | 882 | ||
Therapeutic Interventions | 883 | ||
Pelvic Inflammatory Disease: Sexually Transmitted Infection (STI); Salpingitis; Oophoritis | 884 | ||
Deficient Knowledge | 884 | ||
Common Related Factors | 884 | ||
Defining Characteristics | 884 | ||
Common Expected Outcome | 884 | ||
Ongoing Assessment | 884 | ||
Therapeutic Interventions | 885 | ||
Infection | 886 | ||
Common Related Factors | 886 | ||
Defining Characteristics | 886 | ||
Common Expected Outcome | 886 | ||
Ongoing Assessment | 886 | ||
Therapeutic Interventions | 887 | ||
Acute Pain | 888 | ||
Common Related Factors | 888 | ||
Defining Characteristics | 888 | ||
Common Expected Outcomes | 888 | ||
Ongoing Assessment | 889 | ||
Therapeutic Interventions | 889 | ||
Pelvic Relaxation Disorder: Pelvic Floor Disorders; Uterine Prolapse; Enterocele; Cystocele; Rectocele | 889.e1 | ||
Deficient Knowledge | 889.e1 | ||
Common Related Factors | 889.e1 | ||
Defining Characteristics | 889.e1 | ||
Common Expected Outcome | 889.e1 | ||
Ongoing Assessment | 889.e1 | ||
Therapeutic Interventions | 889.e2 | ||
Stress Urinary Incontinence | 889.e3 | ||
Common Related Factors | 889.e3 | ||
Defining Characteristic | 889.e3 | ||
Common Expected Outcomes | 889.e3 | ||
Ongoing Assessment | 889.e3 | ||
Therapeutic Interventions | 889.e4 | ||
Disturbed Body Image | 889.e5 | ||
Common Related Factors | 889.e5 | ||
Defining Characteristics | 889.e5 | ||
Common Expected Outcomes | 889.e5 | ||
Ongoing Assessment | 889.e5 | ||
Therapeutic Interventions | 889.e5 | ||
Premenstrual Syndrome: Premenstrual Dysphoric Disorder (PMDD) | 889.e6 | ||
Deficient Knowledge | 889.e6 | ||
Common Related Factors | 889.e6 | ||
Defining Characteristics | 889.e6 | ||
Common Expected Outcomes | 889.e7 | ||
Ongoing Assessment | 889.e7 | ||
Therapeutic Interventions | 889.e8 | ||
13 Endocrine and Metabolic Care Plans | 890 | ||
Adrenal Insufficiency (Addison’s Disease): Addisonian Crisis | 890.e1 | ||
Deficient Knowledge | 890.e1 | ||
Common Related Factors | 890.e1 | ||
Defining Characteristics | 890.e1 | ||
Common Expected Outcomes | 890.e1 | ||
Ongoing Assessment | 890.e1 | ||
Therapeutic Interventions | 890.e2 | ||
Risk for Imbalanced Nutrition: Less Than Body Requirements | 890.e2 | ||
Common Risk Factors | 890.e2 | ||
Common Expected Outcomes | 890.e3 | ||
Ongoing Assessment | 890.e3 | ||
Therapeutic Interventions | 890.e3 | ||
Risk for Deficient Fluid Volume | 890.e3 | ||
Common Risk Factors | 890.e3 | ||
Common Expected Outcome | 890.e3 | ||
Ongoing Assessment | 890.e4 | ||
Therapeutic Interventions | 890.e4 | ||
Risk for Decreased Cardiac Output | 890.e5 | ||
Common Risk Factors | 890.e5 | ||
Common Expected Outcome | 890.e5 | ||
Ongoing Assessment | 890.e5 | ||
Therapeutic Interventions | 890.e5 | ||
Cushing’s Disease: Hypercortisolism; Cushing’s Syndrome; Adrenocortical Hyperfunction | 890 | ||
Deficient Knowledge | 890 | ||
Common Related Factors | 890 | ||
Defining Characteristics | 890 | ||
Common Expected Outcomes | 890 | ||
Ongoing Assessment | 891 | ||
Therapeutic Interventions | 891 | ||
Disturbed Body Image | 892 | ||
Common Related Factors | 892 | ||
Defining Characteristics | 892 | ||
Common Expected Outcome | 893 | ||
Ongoing Assessment | 893 | ||
Therapeutic Interventions | 893 | ||
Risk for Injury | 894 | ||
Common Risk Factors | 894 | ||
Common Expected Outcome | 894 | ||
Ongoing Assessment | 894 | ||
Therapeutic Interventions | 895 | ||
Risk for Excess Fluid Volume | 895 | ||
Common Risk Factor | 895 | ||
Common Expected Outcome | 895 | ||
Ongoing Assessment | 895 | ||
Therapeutic Interventions | 896 | ||
Diabetes Insipidus | 896.e1 | ||
Deficient Fluid Volume | 896.e1 | ||
Common Related Factor | 896.e1 | ||
Defining Characteristics | 896.e1 | ||
Common Expected Outcome | 896.e1 | ||
Ongoing Assessment | 896.e1 | ||
Therapeutic Interventions | 896.e2 | ||
Deficient Knowledge | 896.e2 | ||
Common Related Factors | 896.e2 | ||
Defining Characteristics | 896.e2 | ||
Common Expected Outcome | 896.e3 | ||
Ongoing Assessment | 896.e3 | ||
Therapeutic Interventions | 896.e3 | ||
Diabetes Mellitus: Type 1; Type 2 | 896 | ||
Risk for Unstable Blood Glucose Level | 897 | ||
Common Risk Factors | 897 | ||
Common Expected Outcome | 897 | ||
Ongoing Assessment | 897 | ||
Therapeutic Interventions | 899 | ||
Risk for Ineffective Health Management | 902 | ||
Common Risk Factors | 902 | ||
Common Expected Outcomes | 902 | ||
Ongoing Assessment | 902 | ||
Therapeutic Interventions | 902 | ||
Risk for Injury: Feet | 904 | ||
Common Risk Factors | 904 | ||
Common Expected Outcome | 905 | ||
Ongoing Assessment | 905 | ||
Therapeutic Interventions | 906 | ||
Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Nonketotic Syndrome | 907.e1 | ||
Risk for Deficient Fluid Volume | 907.e1 | ||
Common Risk Factors | 907.e1 | ||
Common Expected Outcomes | 907.e1 | ||
Ongoing Assessment | 907.e1 | ||
Therapeutic Interventions | 907.e3 | ||
Hyperthyroidism: Graves’ Disease | 907 | ||
Deficient Knowledge | 907 | ||
Common Related Factors | 907 | ||
Defining Characteristics | 907 | ||
Common Expected Outcome | 908 | ||
Ongoing Assessment | 908 | ||
Therapeutic Interventions | 908 | ||
Imbalanced Nutrition: Less Than Body Requirements | 909 | ||
Common Related Factors | 909 | ||
Defining Characteristics | 909 | ||
Common Expected Outcomes | 910 | ||
Ongoing Assessment | 910 | ||
Therapeutic Interventions | 910 | ||
Disturbed Body Image | 911 | ||
Common Related Factor | 911 | ||
Defining Characteristics | 911 | ||
Common Expected Outcome | 911 | ||
Ongoing Assessment | 911 | ||
Therapeutic Interventions | 911 | ||
Risk for Hyperthermia | 912 | ||
Common Risk Factor | 912 | ||
Common Expected Outcome | 912 | ||
Ongoing Assessment | 912 | ||
Therapeutic Interventions | 912 | ||
Hypothyroidism: Myxedema; Goiter | 913 | ||
Imbalanced Nutrition: More Than Body Requirements | 913 | ||
Common Related Factors | 913 | ||
Defining Characteristics | 913 | ||
Common Expected Outcomes | 914 | ||
Ongoing Assessment | 914 | ||
Therapeutic Interventions | 914 | ||
Fatigue | 915 | ||
Common Related Factor | 915 | ||
Defining Characteristics | 915 | ||
Common Expected Outcomes | 915 | ||
Ongoing Assessment | 915 | ||
Therapeutic Interventions | 915 | ||
Deficient Knowledge | 916 | ||
Common Related Factors | 916 | ||
Defining Characteristics | 916 | ||
Common Expected Outcome | 916 | ||
Ongoing Assessment | 916 | ||
Therapeutic Interventions | 917 | ||
Syndrome of Inappropriate Antidiuretic Hormone (SIADH): Dilutional Hyponatremia | 917.e1 | ||
Excess Fluid Volume | 917.e1 | ||
Common Related Factor | 917.e1 | ||
Defining Characteristics | 917.e1 | ||
Common Expected Outcome | 917.e1 | ||
Ongoing Assessment | 917.e1 | ||
Therapeutic Interventions | 917.e2 | ||
Deficient Knowledge | 917.e2 | ||
Common Related Factors | 917.e2 | ||
Defining Characteristics | 917.e2 | ||
Common Expected Outcome | 917.e3 | ||
Ongoing Assessment | 917.e3 | ||
Therapeutic Interventions | 917.e3 | ||
Thyroidectomy: Hyperthyroidism; Thyrotoxicosis; Thyroid Storm | 917.e3 | ||
Risk for Ineffective Breathing Pattern | 917.e4 | ||
Common Risk Factors | 917.e4 | ||
Common Expected Outcome | 917.e4 | ||
Ongoing Assessment | 917.e4 | ||
Therapeutic Interventions | 917.e5 | ||
Risk for Electrolyte Imbalance: Hypocalcemia | 917.e5 | ||
Common Risk Factor | 917.e5 | ||
Common Expected Outcome | 917.e5 | ||
Ongoing Assessment | 917.e5 | ||
Therapeutic Interventions | 917.e6 | ||
Risk for Injury: Thyroid Storm, Hyperthyroidism | 917.e6 | ||
Common Risk Factors | 917.e6 | ||
Common Expected Outcome | 917.e6 | ||
Ongoing Assessment | 917.e7 | ||
Therapeutic Interventions | 917.e7 | ||
Deficient Knowledge | 917.e7 | ||
Common Related Factors | 917.e7 | ||
Defining Characteristics | 917.e7 | ||
Common Expected Outcome | 917.e7 | ||
Ongoing Assessment | 917.e8 | ||
Therapeutic Interventions | 917.e8 | ||
14 Integumentary Care Plans | 918 | ||
Burns: Partial Thickness Skin Loss; Full Thickness Skin Loss | 918 | ||
Impaired Skin Integrity | 918 | ||
Common Related Factors | 918 | ||
Defining Characteristics | 918 | ||
Common Expected Outcomes | 918 | ||
Ongoing Assessment | 919 | ||
Therapeutic Interventions | 919 | ||
Risk for Infection | 921 | ||
Common Risk Factors | 921 | ||
Common Expected Outcome | 921 | ||
Ongoing Assessment | 921 | ||
Therapeutic Interventions | 921 | ||
Risk for Deficient Fluid Volume | 923 | ||
Common Risk Factors | 923 | ||
Common Expected Outcomes | 923 | ||
Ongoing Assessment | 923 | ||
Therapeutic Interventions | 924 | ||
Risk for Ineffective Breathing Pattern | 924 | ||
Common Risk Factors | 924 | ||
Common Expected Outcome | 924 | ||
Ongoing Assessment | 925 | ||
Therapeutic Interventions | 925 | ||
Acute Pain | 926 | ||
Common Related Factors | 926 | ||
Defining Characteristics | 926 | ||
Common Expected Outcomes | 926 | ||
Ongoing Assessment | 926 | ||
Therapeutic Interventions | 926 | ||
Risk for Ineffective Peripheral Tissue Perfusion | 927 | ||
Common Risk Factors | 927 | ||
Common Expected Outcome | 927 | ||
Ongoing Assessment | 927 | ||
Index | 957 | ||
A | 957 | ||
B | 959 | ||
C | 961 | ||
D | 966 | ||
E | 968 | ||
F | 969 | ||
G | 970 | ||
H | 971 | ||
I | 973 | ||
J | 975 | ||
K | 975 | ||
L | 976 | ||
M | 976 | ||
N | 978 | ||
O | 979 | ||
P | 980 | ||
Q | 983 | ||
R | 983 | ||
S | 985 | ||
T | 988 | ||
U | 989 | ||
V | 990 | ||
W | 990 | ||
X | 991 | ||
Y | 991 | ||
Z | 991 | ||
Inside Back Cover | ibc1 |